IN FORCE Advance Authorisation

DGFT Minutes

Reliability

In force — no superseding record on file.

Document text

Office of Directorate General of Foreign Trade New Delhi -0

------------------------------------------------------------------------------

Para 4.07 Decision

Minutes of the Norms Committee – 3 Meeting No. 4/82-ALC4/2020 dated 18.09.2020 (actually held on 28.09.2020) for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30, held under the Chairmanship of Shri Satyan Sharda, Addl. DGFT in Room No.11, Udyog Bhawan, New Delhi.

Following members were present in the Meeting:

Sl. No.	Name&Designation	Department
1	ShriShaish Kumar,Technical – 1	Consultant
2	Shri D.N. Mathur,Technical – 2	Consultant
In attendance
1	Shri Munish Kumar,Dy. DGFT	DGFT
2	Shri AjayKumar,Assistant Director	DGFT

The committee went through the minutes of earlier meeting No. 3/82-ALC4/2020 dated 07.08.2020 (actually held on 02.09.2020)

ONLINE CASES

Case No.:60/4/82-ALC4/2020	Party Name:HETERO LABS	Meet No/Date:4/82-	Status:
	LTD.	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910038262
:01/82/050/01561/AM21/	:09/24/040/00092/AM10/	17.06.2009

Decision: This case appeared for the first time before Norms Committee. The Committee noted that the 4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019. It was also decided to ask RLA, Hyderabad whether EODC in respect of subject Advance Authorization has been issued to firm or not.

Case No.:56/4/82-ALC4/2020	Party Name:CORAL DRUGS	Meet No/Date:4/82-	Status:
	PVT. LTD.,	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0510287831
:01/82/050/01557/AM21/	:05/23/040/00006/AM12/	08.04.2011

Decision: This case appeared for the first time before Norms Committee. The Committee noted that the 4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019. It was also decided to ask CLA, New Delhi whether EODC in respect of subject Advance Authorization has been issued to firm or not.

firm as per Policy Circular No. 23/2015-20, dated 15.05.2019. It was also decided to ask CLA, New Delhi whether EODC in respect of subject Advance Authorization has been issued to firm or not.

Case No.:969/15/82-	Party Name:SOMU	Meet No/Date:4/82-	Status:
ALC4/2018	SOLVENTS PVT. LTD	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710108673
:01/82/050/02426/AM19/	:07/24/040/00175/AM16/	02.09.2015

3 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 1/82-ALC4/2020 dated 17.04.2020 , followed by Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its 4.07 application, failing which the case will be rejected.

Case No.:405/15/82-	Party Name:SHIVA	Meet No/Date:4/82-	Status:
ALC4/2018	PHARMACHEM LTD,	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:3410041522
:01/82/050/01862/AM19/	:34/24/040/00139/AM16/	16.09.2015

-|---|---| |ALC4/2018||PHARMACHEM LTD,||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:3410041522||| |:01/82/050/01862/AM19/||:34/24/040/00139/AM16/||16.09.2015|||

	Case No.:405/15/82-<br>ALC4/2018	Party Name:SHIVA<br>PHARMACHEM LTD,<br>RLA File<br>:34/24/040/00139/AM16/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved
	HQ File<br>:01/82/050/01862/AM19/		Lic.No/Date:3410041522<br>16.09.2015
4	Decision:The Committee considered case as per agenda in the presence of the technical experts and it was<br>decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>CYCLOPROPANE CARBONYL<br>CHLORIDE<br>APPEARANCE:<br>CLEAR<br>COLOURLESS<br>LIQUID,<br>ASSAY MIN. 99%<br>1 kg<br>1<br>CYCLOPROPANE<br>CARBOXYLIC<br>ACID<br>APPEARANCE<br>:<br>CLEAR<br>COLOURLESS LIQUID, ASSAY<br>MIN. 99%<br>0.9115 kg<br>RA concerned maytake further necessaryaction asper above decision of NC.

Case No.:322/15/82-	Party Name:HESTER	Meet No/Date:4/82-	Status:
ALC4/2018	BIOSCIENCES LIMITED	ALC4/2020	Withdrawn
		18.09.2020
HQ File	RLA File	Lic.No/Date:0810136418
:01/82/050/01779/AM19/	:08/24/040/00270/AM16/	02.11.2015

|---| |ALC4/2018||BIOSCIENCES LIMITED||ALC4/2020||Withdrawn| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0810136418||| |:01/82/050/01779/AM19/||:08/24/040/00270/AM16/||02.11.2015|||

5 Decision: The firm vide letter dated 18.08.2020 has informed that they had surrendered the subject Advance Authorization in RLA, Ahmedabad and on the basis of their request, RLA, Ahmedbad had issued a Surrender Letter to them. The firm has furnished a copy of the Surrender Letter received from RLA, Ahmedabad with the request to close the case.

The Committee considered the case in the presence of technical experts and in light of above letter of firm, it was decided to withdraw the case.

Case No.:1030/15/82-	Party Name:SWATI	Meet No/Date:4/82-	Status:
ALC4/2018	MENTHOL & ALLIED	ALC4/2020	Rejected
	CHEMICALS LTD.,	18.09.2020
HQ File	RLA File	Lic.No/Date:2910025235
:01/82/050/02487/AM19/	:29/21/040/00029/AM16/	21.12.2015

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not furnished the information on following deficiencies raised by NC-3 in its Meeting No. 7/82-ALC4/2019 6 dated 06.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020 :

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield at every stage. (ii) Central Excise or GST Certificate.

Hence, the Committee decided to reject the case.

echnical details chemistry, molecular weight, stoichiometric reaction and % of yield at every stage. (ii) Central Excise or GST Certificate.**

Hence, the Committee decided to reject the case.

RA concerned may take further necessary action as per above decision of NC.

Case No.:260/15/82-	Party Name:VINNY	Meet No/Date:4/82-	Status:
ALC4/2018	HEALTHCARE PRIVATE	ALC4/2020	Rejected
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0810137198
:01/82/050/01717/AM19/	:08/24/040/00386/AM16/	12.02.2016

7 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:221/15/82-	Party Name:GOPINATH	Meet No/Date:4/82-	Status:
ALC4/2018	CHEM-TECH LTD.,	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0810137649
:01/82/050/01678/AM19/	:08/24/040/00469/AM16/	11.04.2016

-|---|---| |ALC4/2018||CHEM-TECH LTD.,||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0810137649||| |:01/82/050/01678/AM19/||:08/24/040/00469/AM16/||11.04.2016|||

	Case No.:221/15/82-<br>ALC4/2018	Party Name:GOPINATH<br>CHEM-TECH LTD.,<br>RLA File<br>:08/24/040/00469/AM16/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved
	HQ File<br>:01/82/050/01678/AM19/		Lic.No/Date:0810137649<br>11.04.2016
8	Decision:The Committee considered case as per agenda in the presence of the technical experts and it was<br>decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>4,4 Diamino Diphenyl Amine -2-<br>Sulphonic Acid ( F.C Acid )<br>1 kg<br>1<br>Para NItro Aniline<br>0.61 kg<br>2<br>Para NItro Chloro Benzene<br>0.70 kg<br>3<br>Soda Ash<br>1.80 kg<br>Note: The Committee while fixing the norms of subject Advance Authorization observed that the<br>Standard Input Output Norms (SION) for the export product -4,4 Diamino Diphenyl Amine -2-<br>Sulphonic Acid are published in SION at A-465 and A-468. As the norms at SION A-465 are more<br>precise,the Committee after deliberation decided to recommend deletingthe norms at SION A-468.<br>RA concerned maytake further necessaryaction asper above decision of NC.

A-465 are more precise,the Committee after deliberation decided to recommend deletingthe norms at SION A-468. RA concerned maytake further necessaryaction asper above decision of NC.||||

Case No.:274/15/82-	Party Name:SHILPA	Meet No/Date:4/82-	Status:
ALC4/2018	MEDICARE LTD.,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710109729
:01/82/050/01731/AM19/	:07/24/040/00034/AM17/	27.04.2016

9 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:230/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710109922
:01/82/050/01687/AM19/	:07/24/040/00083/AM17/	08.06.2016

|---|---|---|---| |ALC4/2018||LIMITED,||ALC4/2020||Rejected| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0710109922||| |:01/82/050/01687/AM19/||:07/24/040/00083/AM17/||08.06.2016|||

10 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:231/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710109921
:01/82/050/01688/AM19/	:07/24/040/00082/AM17/	08.06.2016

11 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

020** as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:501/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710109926
:01/82/050/01958/AM19/	:07/24/040/00081/AM17/	09.06.2016

12 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Case No.:646/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710110596
:01/82/050/02103/AM19/	:07/24/040/00251/AM17/	28.10.2016

13 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:680/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710110805
:01/82/050/02137/AM19/	:07/24/040/00282/AM17/	16.12.2016

14 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:265/15/82-	Party Name:ATUL LIMITED,	Meet No/Date:4/82-	Status:
ALC4/2018		ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0810139395
:01/82/050/01722/AM19/	:08/24/040/00374/AM17/	28.12.2016

|---|---|---|---|---|---| |ALC4/2018||||ALC4/2020||Deferred| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0810139395||| |:01/82/050/01722/AM19/||:08/24/040/00374/AM17/||28.12.2016|||

15 Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was decided to call for following information from the firm:

(i) Exact chemical name of Export Product (ii) % yield of chemical reaction (iii) Use of Methanol in manufacturing process.

Case No.:992/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710111032
:01/82/050/02449/AM19/	:07/24/040/00353/AM17/	27.01.2017

16 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

08.2020** as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:995/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710111117
:01/82/050/02452/AM19/	:07/24/040/00362/AM17/	10.02.2017

17 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:1002/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710111160
:01/82/050/02459/AM19/	:07/24/040/00365/AM17/	21.02.2017

|---|---|---|---| |ALC4/2018||LIMITED,||ALC4/2020||Rejected| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0710111160||| |:01/82/050/02459/AM19/||:07/24/040/00365/AM17/||21.02.2017|||

18 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

19	Case No.:276/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD.,	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01733/AM19/	RLA File<br>:05/23/040/00561/AM17/	Lic.No/Date:0510401758<br>22.02.2017
	Decision:The Committee considered the case as per agenda<br>Show Cause Notice vide letter dated 10.10.2019.		and it was observed that the firm was issued

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

was observed that the firm was issued||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

20	Case No.:55/4/82-ALC4/2020	Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01556/AM21/	RLA File<br>:03/94/040/01066/AM17/	Lic.No/Date:0310811424<br>23.02.2017
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy<br>of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No.<br>23/2015-20,dated 15.05.2019.

Case No.:382/4/82-ALC4/2017	Party Name:ELPPE	Meet No/Date:4/82-	Status:
	CHEMICALS PRIVATE	ALC4/2020	Withdrawn
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0310812684
:01/82/050/00390/AM18/	:03/94/040/00036/AM18/	24.04.2017

|---|---| ||||CHEMICALS PRIVATE||ALC4/2020||Withdrawn| ||||LIMITED||18.09.2020||| ||HQ File||RLA File||Lic.No/Date:0310812684||| ||:01/82/050/00390/AM18/||:03/94/040/00036/AM18/||24.04.2017|||

21 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was observed that the norms for the subject Advance Authorization have already been ratified by NC-3 in its Meeting No. 3/82-ALC4/2020 dated 07.08.2020.

In view of above, the Committee decided to withdraw the case.

22	Case No.:294/15/82-<br>ALC4/2018	Party Name:SUPREET<br>CHEMICALS PVT.LTD.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01751/AM19/	RLA File<br>:52/24/040/00006/AM18/	Lic.No/Date:5210042249<br>02.05.2017
	Decision:The Committee considered the case as per online agenda in the presence of technical experts<br>and it was decided to call for following information from the firm:<br>(i)<br>Recovery of other Isomer and its commercial value.

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was decided to call for following information from the firm:

Case No.:289/15/82-	Party Name:ATUL LIMITED,	Meet No/Date:4/82-	Status:
ALC4/2018		ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0810140311
:01/82/050/01746/AM19/	:08/24/040/00043/AM18/	18.05.2017

|---|---|---|---|---|---| |ALC4/2018||||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0810140311||| |:01/82/050/01746/AM19/||:08/24/040/00043/AM18/||18.05.2017|||

Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: 23

|Export Product<br>Lapox ARD 54 (Diglycidyl ether<br>of polypropylene glycol)|Qty.|Sl.<br>No.|Import items|Qty.|
|---|---|---|---|---|
||1 kg|1|Poly Propylene Glycol | PPG-425 |<br>Konix PP 400 | Wanol C 2004 |<br>Exacol PPG 425|0.7938 kg|
|||2|Epichlorohydrin|0.345 kg|

Case No.:290/15/82-	Party Name:WINTAC	Meet No/Date:4/82-
ALC4/2018	LIMITED,	ALC4/2020
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710111636
:01/82/050/01747/AM19/	:07/24/040/00052/AM18/	23.05.2017

24 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Case No.:291/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710111650
:01/82/050/01748/AM19/	:07/24/040/00056/AM18/	24.05.2017

25 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Case No.:109/12/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065247
:01/82/050/01064/AM18/	:09/24/040/00181/AM18/	06.07.2017

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 26 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

ished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:309/15/82-	Party Name:DISCOVERY	Meet No/Date:4/82-	Status:
ALC4/2018	INTERMEDIATES PVT LTD.	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065252
:01/82/050/01766/AM19/	:09/24/040/00157/AM18/	07.07.2017

Qty.	Sl.<br>No.	Import items	Qty.
1 kg	1	L PHENYLAMINE	0.4465 kg
	2	POTASSIUM CARBONATE	1.075 kg
	3	BENZYL CHLORIDE	1.032 kg
	4	CITRIC ACID	1.000 kg

Case No.:311/15/82-	Party Name:ASSOCIATED	Meet No/Date:4/82-	Status:
ALC4/2018	DYESTUFF PVT. LTD	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0810140725
:01/82/050/01768/AM19/	:08/24/040/00123/AM18/	26.07.2017

---|---| |ALC4/2018||DYESTUFF PVT. LTD||ALC4/2020||Deferred| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0810140725||| |:01/82/050/01768/AM19/||:08/24/040/00123/AM18/||26.07.2017|||

28 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 1/82-ALC4/2020 dated 17.04.2020 , followed by Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its 4.07 application, failing which the case will be rejected.

29	Case No.:297/12/82-<br>ALC4/2018	Party Name:GLOBAL<br>CALCIUM PRIVATE<br>LIMITED,	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Withdrawn
	<br>HQ File<br>:01/82/050/00924/AM19/	RLA File<br>:07/24/040/00129/AM18/	Lic.No/Date:0710111984<br>08.08.2017
	<br>Decision:The firm vide e-mail dated 07.08.2020 has furnished a copy of EODC obtained from RLA,<br>Bangalore.<br>The Committee considered the case in the presence of technical experts and in light of above<br>e-mail,the Committee decided towithdrawthe case.

Case No.:116/12/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065373
:01/82/050/01071/AM18/	:09/24/040/00234/AM18/	23.08.2017

-|---|---|---|---| |ALC4/2017||LIMITED||ALC4/2020||Rejected| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0910065373||| |:01/82/050/01071/AM18/||:09/24/040/00234/AM18/||23.08.2017|||

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 30 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:134/12/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065372
:01/82/050/01089/AM18/	:09/24/040/00233/AM18/	23.08.2017

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 31 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

ed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:131/12/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065396
:01/82/050/01086/AM18/	:09/24/040/00238/AM18/	28.08.2017

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 32 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:132/12/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065398
:01/82/050/01087/AM18/	:09/24/040/00235/AM18/	28.08.2017

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 33 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

ished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:141/12/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065397
:01/82/050/01096/AM18/	:09/24/040/00236/AM18/	28.08.2017

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 34 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:321/15/82-	Party Name:AASHA	Meet No/Date:4/82-	Status:
ALC4/2018	BIOCHEM	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:1010059805
:01/82/050/01778/AM19/	:10/24/040/00018/AM18/	31.08.2017

-|---|---|---|---| |ALC4/2018||BIOCHEM||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:1010059805||| |:01/82/050/01778/AM19/||:10/24/040/00018/AM18/||31.08.2017|||

Decision: The Committee considered case as per agenda in the presence of the technical experts and as per COA of Export Product / Import items, it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export Product<br>SQUALENE<br>99%<br>CHEMICAL NAME 2 6 10 15<br>19 23 HEXAMETHYLETRA<br>COSA 2 6 10 14 18 22<br>HEXAENE	Qty.	Sl.<br>No.	Import items	Qty.
	1 kg	1	SQUALENE<br>OIL<br>80%<br>CHEMICAL NAME 2 6 10 15 19 23<br>HEXAMETHYLETRA COSA 2 6 10 14<br>18 22 HEXAENE	1.185 kg

Case No.:198/4/82-<br>ALC4/2018	Party Name:SAPTAGIR<br>CAMPHOR LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020
HQ File<br>:01/82/050/00198/AM19/	RLA File<br>:09/24/040/00293/AM18/	Lic.No/Date:0910065468<br>15.09.2017
<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and taken<br>into value of By-Product, it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol.<br>I as per details below or as applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>Camphene<br>1 kg<br>1<br>Alpha Pinene<br>1.140 kg
RA concerned maytake further necessaryaction asper above decision of NC.

Export Product Qty. Sl. No. Import items Qty. Camphene 1 kg 1 Alpha Pinene 1.140 kg|||| ||RA concerned maytake further necessaryaction asper above decision of NC.||||

Decision: The Committee considered case as per agenda in the presence of the technical experts and taken 36 into value of By-Product, it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:327/15/82- Party Name:JODAS EXPOIM Meet No/Date:4/82- Status: ALC4/2018 PVT.LTD., ALC4/2020 Deferred 18.09.2020 37 HQ File RLA File Lic.No/Date:0510404290 :01/82/050/01784/AM19/ :05/23/040/00268/AM18/ 13.10.2017

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

38	Case No.:328/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD.,	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01785/AM19/	RLA File<br>:05/23/040/00266/AM18/	Lic.No/Date:0510404285<br>13.10.2017
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

otice vide letter dated 10.10.2019.||||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

39	Case No.:329/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD.,	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01786/AM19/	RLA File<br>:05/23/040/00267/AM18/	Lic.No/Date:0510404287<br>13.10.2017
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

40	Case No.:550/15/82-<br>ALC4/2018	Party Name:TADIMETY<br>AROMATICS PVT. LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02007/AM19/	RLA File<br>:07/24/040/00202/AM18/	Lic.No/Date:0710112366<br>08.11.2017
	<br>Decision:The Committee considered the case as per online agenda in the presence of technical experts<br>and it was decided to call for following information from the firm:<br>(i)<br>Complete technical details as per Appendix 4E having complete chemistry,<br>molecular weight, percentage yield and Stoichiometric balance.

information from the firm: (i) Complete technical details as per Appendix 4E having complete chemistry, molecular weight, percentage yield and Stoichiometric balance.||||

Case No.:236/4/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065688
:01/82/050/00236/AM19/	:09/24/040/00403/AM18/	24.11.2017

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 41 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:243/4/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065687
:01/82/050/00243/AM19/	:09/24/040/00404/AM18/	24.11.2017

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 42 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

ished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:1021/15/82-	Party Name:ANLON	Meet No/Date:4/82-	Status:
ALC4/2018	HEALTHCARE	ALC4/2020	Deferred
	PRIVATELIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:2410042334
:01/82/050/02478/AM19/	:24/24/040/00039/AM18/	12.01.2018

43 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 1/82-ALC4/2020 dated 17.04.2020 , followed by Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its 4.07 application, failing which the case will be rejected.

Case No.:12/4/82-ALC4/2018	Party Name:MELOG	Meet No/Date:4/82-	Status:
	SPECIALITY CHEMICALS	ALC4/2020	Approved
	PVT. LTD.	18.09.2020
HQ File	RLA File	Lic.No/Date:0310818490
:01/82/050/00012/AM19/	:03/95/040/00810/AM18/	15.01.2018

|---|---| |||SPECIALITY CHEMICALS||ALC4/2020||Approved| |||PVT. LTD.||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0310818490||| |:01/82/050/00012/AM19/||:03/95/040/00810/AM18/||15.01.2018|||

Export Product<br>T-2003 (2,2-METHYLEBIS (4,6-<br>DI-TERTIARY-<br>BUTYLPHENOL)	Qty.	Sl.<br>No.	Import items	Qty.
	1 kg	1	2,4-DI-TERTIARY BUTYL PHENOL	1.02 kg

45	Case No.:165/10/82-<br>ALC4/2018	Party Name:AURORE LIFE<br>SCIENCES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00452/AM19/	RLA File<br>:09/24/040/00438/AM18/	Lic.No/Date:0910065915<br>20.01.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 24.08.2020 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 24.08.2020 has furnished its reply. Deferred for comments of TE.

he Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 24.08.2020 has furnished its reply. Deferred for comments of TE.

Case No.:187/10/82-	Party Name:NISARG	Meet No/Date:4/82-	Status:
ALC4/2018	BIOSCIENCES PVT LTD	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065945
:01/82/050/00474/AM19/	:09/24/040/00497/AM18/	31.01.2018

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 46 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020 :

(i) Exact chemical name of the export product.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

47	<br>Case No.:132/10/82-<br>ALC4/2018	Party Name:AURORE LIFE<br>SCIENCES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00419/AM19/	RLA File<br>:09/24/040/00516/AM18/	Lic.No/Date:0910065954<br>01.02.2018
	Decision:Deferred for comments of TE.

rred**| |---|---|---|---|---| || HQ File :01/82/050/00419/AM19/|RLA File :09/24/040/00516/AM18/|Lic.No/Date:0910065954 01.02.2018|| ||**Decision:**Deferred for comments of TE.||||

Case No.:135/10/82-	Party Name:NISARG	Meet No/Date:4/82-	Status:
ALC4/2018	BIOSCIENCES PVT LTD	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065963
:01/82/050/00422/AM19/	:09/24/040/00498/AM18/	02.02.2018

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 48 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020 :

(i) Percentage yield on molar basis at every stage. (ii) Exact chemical name of the export product.

49	<br>Case No.:140/10/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00427/AM19/	RLA File<br>:09/24/040/00527/AM18/	Lic.No/Date:0910065968<br>06.02.2018
	Decision:Deferred for comments of TE.

Case No.:142/4/82-	Party Name:HERBOCHEM	Meet No/Date:4/82-	Status:
ALC4/2018	INDUSTRIES	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0610038810
:01/82/050/00142/AM19/	:06/24/040/00047/AM18/	07.02.2018

--|---|---|---| |ALC4/2018||INDUSTRIES||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0610038810||| |:01/82/050/00142/AM19/||:06/24/040/00047/AM18/||07.02.2018|||

Decision: The Committee considered case as per agenda in the presence of the technical experts and with 2% wastage, it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Sl.	Export Product	Qty.	Sl.	Import items	Qty.
No.			No.
1	MENTHOL	8928.000 kg	1	MENTHA ARVENSIS	14247.36 kg
2	DEMENTHOLISED	3960.000 kg		OIL
	PEPPERMINT OIL
3	CORNMINT FRACTION OR	1080.000 kg
	MINT TERPENE

Case No.:166/10/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910065973
:01/82/050/00453/AM19/	:09/24/040/00528/AM18/	07.02.2018

|---|---| |ALC4/2018||LABORATORIES LTD||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0910065973||| |:01/82/050/00453/AM19/||:09/24/040/00528/AM18/||07.02.2018|||

	Case No.:166/10/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved
	HQ File<br>:01/82/050/00453/AM19/	RLA File<br>:09/24/040/00528/AM18/				Lic.No/Date:0910065973<br>07.02.2018
51	Decision:The Committee considered cas<br>was decided to ratify the ad-hoc input output<br>applied by firm whichever is lower:
	Export Product		Qty.	Sl.<br>No.	Import items		Qty.
	2S,3S,5S)-2-AMINO-3-<br>HYDROXY-5-(1-TETRA-<br>HYDRO PYRIMID-2-ONLY)-3-<br>METHYL<br>BUTANOYL)<br>AMINO-1,6-DIPHENYL<br>HEXANE-S-PYRO<br>GLUTAMATE(THP)		1 kg	1	L-PHENYLALANINE		0.473 kg
				2	1,2 DIMETHOXYETHANE		6.74 kg
				3	SODIUM BORO HYDRIDE		0.406 kg
				4	METHANE SULPHONIC ACID		1.57 kg
				5	ISOPROPYL ALCOHOL		1.27 kg
				6	TRIETHANOLAMINE(99%)		1.167 kg
				7	N,N-DIMETHYL ACETAMIDE		1.60 kg
				8	L- VALINE		0.630 kg
				9	ACRELONITRILE		0.277 kg
				10	MDC		3.25 kg
				11	N,N- CARBONYL DIMIDAZOLE		0.443 kg
				12	AMMONIUM FORMATE		0.500 kg
				13	DIMETHYL FORMAMIDE		3.945 kg
				14	L-PYROGLUTAMIC ACID		0.295 kg
				15	n- HEPTANE		0.450 kg
				16	TETRAHYDROFURAN		2.445 kg

ZOLE|||0.443 kg| |||||12|AMMONIUM FORMATE|||0.500 kg| |||||13|DIMETHYL FORMAMIDE|||3.945 kg| |||||14|L-PYROGLUTAMIC ACID|||0.295 kg| |||||15|n- HEPTANE|||0.450 kg| |||||16|TETRAHYDROFURAN|||2.445 kg| |||||17|SODIUM AMIDE|||0.378 kg| |||||18|ACETONITRILE|||0.300 kg| |||||19|PALLADIUM 99.95%|||0.001 kg| |||||20|POTTASIUM CARBONATE|||1.50 kg| |||||21|CITRIC ACID|||2.00 kg| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

52	Case No.:819/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02276/AM19/	Party Name:DHANUKA<br>LABORATORIES LTD<br> <br> <br> <br>RLA File<br>:05/23/040/00440/AM18/<br> <br>	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
			Lic.No/Date:0510405609<br>09.02.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No.<br>1/82-ALC4/2020dated17.04.2020, followed by Reminder on07.08.2020as per Policy Circular No.<br>23/2015-20, dated 15.05.2019.<br>In view of above, the Committee decided to issueFinal Reminderto firm to furnish its 4.07<br>application,failingwhich the case will be rejected.

o. 23/2015-20, dated 15.05.2019. In view of above, the Committee decided to issueFinal Reminderto firm to furnish its 4.07 application,failingwhich the case will be rejected.||||

53	Case No.:1009/15/82-<br>ALC4/2018	Party Name:TADIMETY<br>AROMATICS PVT. LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02466/AM19/	RLA File<br>:07/24/040/00305/AM18/	Lic.No/Date:0710112820<br>13.02.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 16.11.2019 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 16.11.2019 has furnished its reply. Deferred for comments of TE.

Case No.:82/10/82-ALC4/2018	Party Name:FRESENIUS KABI	Meet No/Date:4/82-	Status:
	INDIA PRIVATE LTD	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0310819230
:01/82/050/00369/AM19/	:03/94/040/00911/AM18/	19.02.2018

54 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was observed that the reply furnished by the firm was not proper. Hence, the Committee decided to reject the case.

onsidered the case as per agenda in the presence of technical experts and it was observed that the reply furnished by the firm was not proper. Hence, the Committee decided to reject the case.

55	Case No.:93/10/82-<br>ALC4/2018	Party Name:YASHO<br>INDUSTRIES PVT.LTD.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00380/AM19/	RLA File<br>:03/95/040/01007/AM18/	Lic.No/Date:0310819263<br>20.02.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 24.10.2019 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 24.10.2019 has furnished its reply. Deferred for comments of TE.

Case No.:47/13/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066003
:01/82/050/01025/AM19/	:09/24/040/00587/AM18/	20.02.2018

a in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: 56

Qty.	Sl.<br>No.	Import items	Qty.
1 kg	1	2,3-dihydrofuran	1.05 kg
	2	Triethyl amine	2.05 kg
	3	Methelene dichloride	3.30 kg
	4	Sodium borohydride	0.72 kg

Case No.:186/13/82-	Party Name:SONGWON	Meet No/Date:4/82-	Status:
ALC4/2018	SPECIALTY CHEMICALS	ALC4/2020	Deferred
	INDIA PVT. LTD.	18.09.2020
HQ File	RLA File	Lic.No/Date:3410043908
:01/82/050/01164/AM19/	:34/24/040/00341/AM18/	22.02.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was observed that the reply furnished by the firm in response to earlier issued DL was not proper. Hence, it was decided to call for following information from the firm:

(i) % yield on molar basis at every stage.

Case No.:286/4/82-ALC4/2018	Party Name:SURVIVAL	Meet No/Date:4/82-	Status:
	TECHNOLOGIES PVT.LTD.	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0310819412
:01/82/050/00286/AM19/	:03/95/040/00993/AM18/	26.02.2018

|---|---|---|---| |||TECHNOLOGIES PVT.LTD.||ALC4/2020||Deferred| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0310819412||| |:01/82/050/00286/AM19/||:03/95/040/00993/AM18/||26.02.2018|||

58 Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was observed that the reply furnished by the firm in response to earlier issued DL was not proper. Hence, it was decided to call for following information from the firm:

(i) Production / Consumption data duly certified by GST for last one year. (ii) Use of Acetonitrile in manufacturing. (iii) Recovery of N-Hexane.

Case No.:125/13/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066054
:01/82/050/01103/AM19/	:09/24/040/00611/AM18/	12.03.2018

	Case No.:125/13/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved
	HQ File<br>:01/82/050/01103/AM19/	RLA File<br>:09/24/040/00611/AM18/				Lic.No/Date:0910066054<br>12.03.2018
59	Decision:The Committee considered cas<br>was decided to ratify the ad-hoc input output<br>applied by firm whichever is lower:
	Export Product		Qty.	Sl.<br>No.	Import items		Qty.

|| |59|**Decision:**The Committee considered cas was decided to ratify the ad-hoc input output applied by firm whichever is lower:|||||||| ||Export Product||Qty.|Sl. No.|Import items|||Qty.| ||[2S,3S,5S]-5-t- butyloxycarbonylamino-2- Amino-3-hydroxy-1,6- diphenylhexane succinate(BDH Succinic Acid RIT)||1 kg|1|1,2-dimethoxyethane(1,2-DME)|||4.74 kg| |||||2|SODIUM BORO HYDRIDE|||0.45 kg| |||||3|METHANE SULPHONIC ACID|||1.50 kg| |||||4|ISOPROPYL ALCOHOL|||2.90 kg| |||||5|TRIETHANOLAMINE|||1.167 kg| |||||6|N,N-DIMETHYL ACETAMIDE|||0.80 kg| |||||7|AMMONIUM FORMATE|||0.50 kg| |||||8|POTTASIUM CARBONATE|||0.40 kg| |||||9|Di-Tert-Butyl- Di- Carbonate|||0.60 kg| |||||10|Methylene Dichloride(MDC)|||1.34 kg| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

Case No.:33/13/82-ALC4/2018	Party Name:VISWAAT	Meet No/Date:4/82-	Status:
	CHEMICALS LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0310819857
:01/82/050/01011/AM19/	:03/95/040/01027/AM18/	16.03.2018

|---|---|---|---|---| |||CHEMICALS LIMITED||ALC4/2020||Rejected| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0310819857||| |:01/82/050/01011/AM19/||:03/95/040/01027/AM18/||16.03.2018|||

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm was asked to furnish following information asked for by NC-3 in its Meeting No. 9/82-ALC4/2019 dated 18.10.2019, followed by Reminder on 09.12.2019 and Final Reminder on 13.02.2020:

(i) Indigenous input and their quantity.

The firm vide e-mail dated 14.02.2020 instead of giving reply to the above query referred to the Minutes of NC-3 Meeting No. 5/82-ALC4/2019 dated 25.07.2018 vide which NC fixed norms of their Advance Authorization No. 0310808110 dated 27.09.2016.

The Committee examined the above e-mail received from firm in light of norms fixed for Advance Authorization No. 0310808110 dated 27.09.2016 vide NC-3 Meeting No. 5/82-ALC4/2019 dated 25.07.2018 and it was observed that NC while fixing the norms of Advance Authorization No. 0310808110 dated 27.09.2016 clearly mentioned that the norms allowed are for one time basis and repeat norms will be allowed.

In view of above, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

for one time basis and repeat norms will be allowed.**

In view of above, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:127/13/82-	Party Name:SPANSULES	Meet No/Date:4/82-	Status:
ALC4/2018	FORMULATIONS	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066066
:01/82/050/01105/AM19/	:09/24/040/00619/AM18/	20.03.2018

Sl. No.<br>1<br>2	Export Product	Qty.	Sl.<br>No.	Import items	Qty.
	Ascorbic Acid 85% SR Pellets	7.070 MT	1	Ascorbic Acid	6.07 MT
	Ascorbic<br>Acid<br>and<br>other<br>multivitamin Pellets (containing not<br>less than 50% Ascorbic Acid)	30.000 MT	2	Ascorbic Acid	15.00 MT

5% SR Pellets|7.070 MT|1|Ascorbic Acid|6.07 MT| ||Ascorbic Acid and other multivitamin Pellets (containing not less than 50% Ascorbic Acid)|30.000 MT|2|Ascorbic Acid|15.00 MT|

Case No.:258/12/82-<br>ALC4/2018	Party Name:SYNTHO<br>CHIRALS PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020
HQ File<br>:01/82/050/00885/AM19/	RLA File<br>:09/24/040/00669/AM18/	Lic.No/Date:0910066087<br>26.03.2018
<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>(1R,2R)-2-amino-6-(4-nitrophenyl)-1-<br>Phenylhex-5-yn-1-ol hydrochloride<br>400 kg<br>1<br>KRED,<br>RVT-901<br>(Enzyme)<br>5000.000 gram
RA concerned maytake further necessaryaction asper above decision of NC.

in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as 62 applied by firm whichever is lower:

Case No.:126/13/82-	Party Name:OPTRIX	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES PRIVATE	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0910066086
:01/82/050/01104/AM19/	:09/24/040/00639/AM18/	26.03.2018

	Case No.:126/13/82-<br>ALC4/2018	Party Name:OPTRIX<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved
	HQ File<br>:01/82/050/01104/AM19/	RLA File<br>:09/24/040/00639/AM18/	Lic.No/Date:0910066086<br>26.03.2018
63	<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>EMPAGLIFLOZIN IH<br>1 kg<br>1<br>(1S)-1 5-Anhydro-1-C-[4-chloro -3-[[4-[[(3S)-<br>tetrahydro-3-<br>furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol<br>tetraacetate<br>OR<br>(1S)-1<br>5-Anhydro-1-C-[4-chloro<br>-3-[[4-<br>[[(3S)-tetrahydro-3-<br>furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol<br>1.525 kg<br>RA concerned may take further necessary action as per above decision of NC.

ydro-1-C-[4-chloro -3-[[4- [[(3S)-tetrahydro-3- furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol 1.525 kg RA concerned may take further necessary action as per above decision of NC.||||

Case No.:5/10/82-	Party Name:DCM SHRIRAM	Meet No/Date:4/82-	Status:
ALC4/2018	INDUSTRIES LTD,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0510406067
:01/82/050/00292/AM19/	:05/23/040/00515/AM18/	09.04.2018

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 64 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020 :

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield on molar basis at every stage.

0.2019** and Final Reminder on 13.02.2020 :

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield on molar basis at every stage.

65	Case No.:1014/15/82-<br>ALC4/2018	Party Name:TADIMETY<br>AROMATICS PVT. LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02471/AM19/	RLA File<br>:07/24/040/00361/AM18/	Lic.No/Date:0710113089<br>10.04.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 16.11.2019 has furnished its reply. Deferred for comments of TE.

66	Case No.:261/12/82-<br>ALC4/2018	Party Name:AKTINOS<br>HEALTHCARE PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	HQ File<br>:01/82/050/00888/AM19/	RLA File<br>:09/24/040/00668/AM18/	Lic.No/Date:0910066131<br>11.04.2018
	<br>Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was decided to call for following information from the firm:<br>(i)<br>Whether export item is physical blending of two compounds as mentioned in<br>**export description.

cal experts and it was decided to call for following information from the firm: (i) Whether export item is physical blending of two compounds as mentioned in export description. If no, please give the chemical name of the export item. (ii) Molecular weight of export item and its chemical structure. (iii) Use of D-(-) Threo compound in the final step.||||

Case No.:156/13/82-	Party Name:SMS	Meet No/Date:4/82-	Status:
ALC4/2018	LIFESCIENCES INDIA	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0910066137
:01/82/050/01134/AM19/	:09/24/040/00654/AM18/	12.04.2018

	Case No.:156/13/82-<br>ALC4/2018	Party Name:SMS<br>LIFESCIENCES INDIA<br>LIMITED	Party Name:SMS<br>LIFESCIENCES INDIA<br>LIMITED	Party Name:SMS<br>LIFESCIENCES INDIA<br>LIMITED	Party Name:SMS<br>LIFESCIENCES INDIA<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved	Status:<br>Approved
	HQ File<br>:01/82/050/01134/AM19/	RLA File<br>:09/24/040/00654/AM18/				Lic.No/Date:0910066137<br>12.04.2018
67	<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol.

||| |67| **Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export Product Qty. Sl. No. Import items Qty. (3R, 3aS, 6aR) - HEXA HYDRO FURO - [2, 3-b] - FURAN - 3 - YL - 4 - NITRO PHENYL CARBONATE (DARUNAVIR-IV) Intermediate of Darunavir 1 kg 1 BIS IV (HEXA HYDRO FURO [2,3-B] FURAN-3-OL) 1.61 kg 2 METHYLENE DI CHLORIDE 5.32 kg RA concerned may take further necessary action as per above decision of NC.|||||||| || Export Product||Qty.|Sl. No.|Import items|||Qty.| ||(3R, 3aS, 6aR) - HEXA HYDRO FURO - [2, 3-b] - FURAN - 3 - YL - 4 - NITRO PHENYL CARBONATE (DARUNAVIR-IV) Intermediate of Darunavir||1 kg|1|BIS IV (HEXA HYDRO FURO [2,3-B] FURAN-3-OL)|||1.61 kg| |||||2|METHYLENE DI CHLORIDE|||5.32 kg| ||RA concerned may take further necessary|||action as|per above decision of NC.||||

enda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

68	<br>Case No.:26/15/82-ALC4/2018	Party Name:GLAND<br>CHEMICALS PVT LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01483/AM19/	RLA File<br>:09/24/040/00008/AM19/	Lic.No/Date:0910066148<br>17.04.2018
	Decision:Deferred for comments of TE.

Case No.:122/13/82-	Party Name:SUVEN LIFE	Meet No/Date:4/82-	Status:
ALC4/2018	SCIENCES LIMITED	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066156
:01/82/050/01100/AM19/	:09/24/040/00024/AM19/	18.04.2018

	Case No.:122/13/82-<br>ALC4/2018	Party Name:SUVEN LIFE<br>SCIENCES LIMITED	Party Name:SUVEN LIFE<br>SCIENCES LIMITED	Party Name:SUVEN LIFE<br>SCIENCES LIMITED	Party Name:SUVEN LIFE<br>SCIENCES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved	Status:<br>Approved
	HQ File<br>:01/82/050/01100/AM19/	RLA File<br>:09/24/040/00024/AM19/				Lic.No/Date:0910066156<br>18.04.2018
69	<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it was<br>decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol.

||| |69| **Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export Product Qty. Sl. No. Import items Qty. 1-(2-FLUORO-6- (TRIFLUOROMETHYL)BENZYL)- 5-IODO-6-METHYLPYRIMIDINE- 2,4 (1H,3H)-DIONE 1 kg 1 3-FLUORO BENZOTRIFLUORIDE 1.011 kg 2 DIMETHYL FORMAMIDE 0.472 kg 3 TETRAHYDROFURAN 0.80 kg 4 METHYL-1-t-BUTYLETHER (MTBE) 0.255 kg 5 IODINE MONOCHLORIDE 0.411 kg RA concerned maytake further necessaryaction asper above decision of NC.|||||||| || Export Product||Qty.|Sl. No.|Import items|||Qty.| ||1-(2-FLUORO-6- (TRIFLUOROMETHYL)BENZYL)- 5-IODO-6-METHYLPYRIMIDINE- 2,4 (1H,3H)-DIONE||1 kg|1|3-FLUORO BENZOTRIFLUORIDE|||1.011 kg| |||||2|DIMETHYL FORMAMIDE|||0.472 kg| |||||3|TETRAHYDROFURAN|||0.80 kg| |||||4|METHYL-1-t-BUTYLETHER (MTBE)|||0.255 kg| |||||5|IODINE MONOCHLORIDE|||0.411 kg| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:6/15/82-ALC4/2018	Party Name:AUROBINDO	Meet No/Date:4/82-	Status:
	PHARMA LIMITED	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066157
:01/82/050/01463/AM19/	:09/24/040/00015/AM19/	18.04.2018

	Case No.:6/15/82-ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0910066157<br>18.04.2018	Status:<br>Approved
	HQ File<br>:01/82/050/01463/AM19/	RLA File<br>:09/24/040/00015/AM19/
70	Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol.

/|||||| |70|**Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export Product Qty. Sl. No. Import items Qty. Clindamycin Palmitate Hydrochloride 1 kg 1 Clindamycin Hydrochloride 1.06 kg 2 Sulfolane Anhydrous 0.31 kg 3 Pyridine 0.18 kg 4 Acetone 2.10 kg 5 Acetonitrile 3.00 kg 6 Cyclohexane(Benzene free) 0.57 kg 7 Methanol(Methyl Alcohol) 0.13 kg 8 Methylene Chloride(MDC) 2.06 kg RA concerned may take further necessary action as per above decision of NC.||||||| ||Export Product||Qty.|Sl. No.|Import items||Qty.| ||Clindamycin Palmitate Hydrochloride||1 kg|1|Clindamycin Hydrochloride||1.06 kg| |||||2|Sulfolane Anhydrous||0.31 kg| |||||3|Pyridine||0.18 kg| |||||4|Acetone||2.10 kg| |||||5|Acetonitrile||3.00 kg| |||||6|Cyclohexane(Benzene free)||0.57 kg| |||||7|Methanol(Methyl Alcohol)||0.13 kg| |||||8|Methylene Chloride(MDC)||2.06 kg| ||RA concerned may take further necessary action as||||per above decision of NC.|||

enda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:153/12/82-	Party Name:ETERNIS FINE	Meet No/Date:4/82-	Status:
ALC4/2018	CHEMICALS LIMITED,	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0310820647
:01/82/050/00780/AM19/	:03/94/040/00055/AM19/	25.04.2018

Export Product	Qty.	Sl.<br>No.	Import items	Qty.
1-[1,6-dimethyl-4-(4-methylpent-<br>3-enyl)-3-cyclohexen-1-yl]ethan-<br>1-one	1 kg	1	METHYL ETHYL KETONE(MEK)	0.4732 kg
		2	MYRCENE	0.7265kg

Case No.:121/13/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066198
:01/82/050/01099/AM19/	:09/24/040/00044/AM19/	04.05.2018

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 72 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

ished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:225/10/82-	Party Name:DR J	Meet No/Date:4/82-	Status:
ALC4/2018	PHARMACHEM PRIVATE	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:3110067038
:01/82/050/00512/AM19/	:31/83/040/00014/AM19/	07.05.2018

Export Product<br>POTASSIUM BENZOATE	Qty.	Sl.<br>No.	Import items	Qty.
	1 kg	1	BENZENE CARBOXYLIC ACID<br>FINE POWDER	0.80 kg
		2	CAUSTIC POTASH FLAKES	0.368 kg

Case No.:107/13/82-	Party Name:OPTRIX	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES PRIVATE	ALC4/2020	Deferred
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0910066210
:01/82/050/01085/AM19/	:09/24/040/00006/AM19/	09.05.2018

74 Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to call for following information from the firm:

006/AM19/||09.05.2018|||

74 Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to call for following information from the firm:

(i) Import item does not match with details given in Appendix 4E. Please clarify it.

Case No.:250/10/82-	Party Name:AETHER	Meet No/Date:4/82-	Status:
ALC4/2018	INDUSTRIES LIMITED	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:5210042638
:01/82/050/00537/AM19/	:52/24/040/00016/AM19/	10.05.2018

Decision: The Committee considered case as per agenda in the presence of the technical experts and it 75 was decided to call for following information from the firm:

(i) Molecular weight of each raw material and finished product. (ii) Use of import item No. 2 (Sodium Tert Butoxide) in reaction and import item No. 5 (Tetrahydrofuran). (iii) % yield of reaction with stoichiometric balance. (iv) Recovery of solvents.

Case No.:366/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710113260
:01/82/050/01823/AM19/	:07/24/040/00008/AM19/	10.05.2018

|---|---|---|---| |ALC4/2018||LIMITED,||ALC4/2020||Rejected| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0710113260||| |:01/82/050/01823/AM19/||:07/24/040/00008/AM19/||10.05.2018|||

76 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

Hence, the Committee decided to reject the case. RA concerned may take further necessary action as per above decision of NC.

Case No.:120/13/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066236
:01/82/050/01098/AM19/	:09/24/040/00614/AM18/	15.05.2018

|---|---| |ALC4/2018||LABORATORIES LTD||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0910066236||| |:01/82/050/01098/AM19/||:09/24/040/00614/AM18/||15.05.2018|||

	Case No.:120/13/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0910066236<br>15.05.2018	Status:<br>Approved
	HQ File<br>:01/82/050/01098/AM19/	RLA File<br>:09/24/040/00614/AM18/
77	<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>[2S,3S,5S]-5-t-<br>butyloxycarbonylamino-2-<br>Amino-3-hydroxy-1,6-<br>diphenylhexane<br>succinate(BDH<br>Succinic Acid RIT)<br>1 kg<br>1<br>1,2-dimethoxyethane(1,2-DME)<br>4.74 kg<br>2<br>SODIUM BORO HYDRIDE<br>0.45 kg<br>3<br>METHANE SULPHONIC ACID<br>1.50 kg<br>4<br>ISOPROPYL ALCOHOL<br>2.90 kg<br>5<br>TRIETHANOLAMINE<br>1.167 kg<br>6<br>N,N-DIMETHYL ACETAMIDE<br>0.80 kg<br>7<br>AMMONIUM FORMATE<br>0.500 kg<br>8<br>POTTASIUM CARBONATE<br>0.40 kg<br>9<br>Di-Tert-Butyl- Di- Carbonate<br>0.60 kg<br>10<br>Methylene Dichloride(MDC)<br>1.34 kg<br>RA concerned maytake further necessaryaction asper above decision of NC.

M CARBONATE 0.40 kg 9 Di-Tert-Butyl- Di- Carbonate 0.60 kg 10 Methylene Dichloride(MDC) 1.34 kg RA concerned maytake further necessaryaction asper above decision of NC.||||||| ||Export Product||Qty.|Sl. No.|Import items||Qty.| || [2S,3S,5S]-5-t- butyloxycarbonylamino-2- Amino-3-hydroxy-1,6- diphenylhexane succinate(BDH Succinic Acid RIT)||1 kg|1|1,2-dimethoxyethane(1,2-DME)||4.74 kg| |||||2|SODIUM BORO HYDRIDE||0.45 kg| |||||3|METHANE SULPHONIC ACID||1.50 kg| |||||4|ISOPROPYL ALCOHOL||2.90 kg| |||||5|TRIETHANOLAMINE||1.167 kg| |||||6|N,N-DIMETHYL ACETAMIDE||0.80 kg| |||||7|AMMONIUM FORMATE||0.500 kg| |||||8|POTTASIUM CARBONATE||0.40 kg| |||||9|Di-Tert-Butyl- Di- Carbonate||0.60 kg| |||||10|Methylene Dichloride(MDC)||1.34 kg| ||RA concerned maytake further necessaryaction as||||per above decision of NC.|||

78	<br>Case No.:18/13/82-ALC4/2018	Party Name:SMS<br>LIFESCIENCES INDIA<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00996/AM19/	RLA File<br>:09/24/040/00067/AM19/	Lic.No/Date:0910066242<br>18.05.2018
	Decision:Deferred for comments of TE.

Deferred*| |---|---|---|---|---| || HQ File :01/82/050/00996/AM19/|RLA File :09/24/040/00067/AM19/|Lic.No/Date:0910066242 18.05.2018|| ||**Decision:**Deferred for comments of TE.||||

Case No.:168/12/82-	Party Name:MANGALAM	Meet No/Date:4/82-	Status:
ALC4/2018	ORGANICS LIMITED	ALC4/2020	Deferred
	FORMERLY DUJODWALA	18.09.2020
	PRODU
HQ File	RLA File	Lic.No/Date:0310821107
:01/82/050/00795/AM19/	:03/95/040/01140/AM18/	21.05.2018

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm was asked to furnish following information asked for by NC-3 in its Meeting No. 8/82-ALC4/2019 dated 20.09.2019 , followed by Reminder on 31.10.2019 and Final Reminder on 79 13.02.2020 :

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield at every stage.

However, the firm vide e-mail dated 23.09.2020 has stated that due to Covid - 19, staff of its Mumbai office is not regular. Hence it will not be able to submit the documents on time. Accordingly, the firm has requested to grant 30 days time for submission of information / documents.

The Committee considered the above request of firm and it was decided to grant 30 days time to firm to furnish its reply.

equested to grant 30 days time for submission of information / documents.

The Committee considered the above request of firm and it was decided to grant 30 days time to firm to furnish its reply.

80	Case No.:373/15/82-<br>ALC4/2018	Party Name:TADIMETY<br>AROMATICS PVT. LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01830/AM19/	RLA File<br>:07/24/040/00046/AM19/	Lic.No/Date:0710113330<br>25.05.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 16.11.2019 has furnished its reply. Deferred for comments of TE.

Case No.:39/13/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066291
:01/82/050/01017/AM19/	:09/24/040/00082/AM19/	01.06.2018

a in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as 81 applied by firm whichever is lower:

Export Product<br>(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-<br>ol(BIS-IV)	Qty.	Sl.<br>No.	Import items	Qty.
	1 kg	1	2,3-dihydrofuran	1.05 kg
		2	Sodium borohydride	0.72 kg

Case No.:376/15/82-	Party Name:GRANULES	Meet No/Date:4/82-
ALC4/2018	INDIA LIMITED	ALC4/2020
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066295
:01/82/050/01833/AM19/	:09/24/040/00099/AM19/	04.06.2018

82 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

83	Case No.:378/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD<br>RLA File<br>:05/23/040/00080/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01835/AM19/		Lic.No/Date:0510406733<br>05.06.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

o/Date:0510406733 05.06.2018|| ||**Decision:**The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.||||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

84	Case No.:379/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD<br>RLA File<br>:05/23/040/00070/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01836/AM19/		Lic.No/Date:0510406734<br>05.06.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

85	Case No.:380/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD<br>RLA File<br>:05/23/040/00022/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01837/AM19/		Lic.No/Date:0510406736<br>05.06.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Case No.:279/10/82-	Party Name:J.B. CHEMICALS	Meet No/Date:4/82-	Status:
ALC4/2018	& PHARMACEUTICALS	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0310821556
:01/82/050/00566/AM19/	:03/94/040/00207/AM19/	08.06.2018

| |ALC4/2018||& PHARMACEUTICALS||ALC4/2020||Approved| |||LIMITED||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0310821556||| |:01/82/050/00566/AM19/||:03/94/040/00207/AM19/||08.06.2018|||

	Case No.:279/10/82-<br>ALC4/2018	Case No.:279/10/82-<br>ALC4/2018	Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED	Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED	Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED	<br>Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0310821556<br>08.06.2018	Status:<br>Approved
	HQ File<br>:01/82/050/00566/AM19/		RLA File<br>:03/94/040/00207/AM19/
86	Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as<br>applied by firm whichever is lower:
	Sl.<br>No,	Export Product		Qty.	Sl.<br>No.	Import items	Qty.
	1	Benzydamine Hydrochloride and<br>Cetylpyridinium Chloride Anti-<br>Inflammatory<br>and Antiseptic Lozenges Sugar<br>Free and all other flavours.

xport Product||Qty.|Sl. No.|Import items||Qty.| ||1|Benzydamine Hydrochloride and Cetylpyridinium Chloride Anti- Inflammatory and Antiseptic Lozenges Sugar Free and all other flavours. Each Lozenge contains (i) Benzydamine Hydrochloride 3 mg (ii) Cetylpyridinium Chloride 1.33 mg (iii) Isomalt ST-M 2700.54 mg. Net content (i) 49.394 Kgs (ii) 21.898 Kgs(iii)44463.116 Kgs.||1 Number Lozenges|1|Benzydamine Hydrochloride||3.06 mg| ||||||2|Cetylpyridinium Chloride||1.357 mg| ||||||3|Isomalt ST-M||2700.54 mg| ||2|Cetylpyridinium Chloride and Bromhexine Hydrochloride Antiseptic Lozenges Sugar Free and all other flavours. Each Lozenge contains (i) Cetylpyridinium Chloride 1.33 mg (ii) Isomalt ST-M - 2700.54 mg. Net content (i) 7.299 Kgs (ii) 14821.039 Kgs.||1 Number Lozenges|4|Cetylpyridinium Chloride||1.357 mg| ||||||5|Isomalt ST-M||2700.54 mg| ||3|Cetylpyridinium Chloride and Benzydamine Hydrochloride Antiseptic Lozenges Sugar Free. Each Lozenge contains (i) Cetylpyridinium Chloride 1 mg (ii) Isomalt ST-M - 2700.54 mg. Net Content (i) 7.299 Kgs (ii) 19711.998 Kgs.||1 Number Lozenges|6|Cetylpyridinium Chloride||1.02 mg| ||||||7|Isomalt ST-M||2700.54 mg| ||4|Zecuf Herbal Cough Lozenges Sugar Free Each Lozenge contains Isomalt ST- M - 2700.54 mg. Net content 5929.695 Kgs.||1 Number Lozenges|8|Isomalt ST-M||2700.54 mg| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

somalt ST- M - 2700.54 mg. Net content 5929.695 Kgs.||1 Number Lozenges|8|Isomalt ST-M||2700.54 mg| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

Case No.:81/12/82-	Party Name:KOPRAN	Meet No/Date:4/82-	Status:
ALC4/2018	RESEARCH	ALC4/2020	Approved
	LABORATORIES LTD.	18.09.2020
HQ File	RLA File	Lic.No/Date:0310821554
:01/82/050/00708/AM19/	:03/94/040/00194/AM19/	08.06.2018

Export Product<br>LYMECYCLINE	Qty.	Sl.<br>No.	Import items	Qty.
	1 kg	1	TETRACYCLINE HYDROCHLORIDE	0.91 kg
		2	L-LYSINE MONO HYDROCHLORIDE	0.33 kg

88	<br>Case No.:60/15/82-ALC4/2018	Party Name:ALPHAMED<br>FORMULATIONS P LTD.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01517/AM19/	RLA File<br>:09/24/040/00075/AM19/	Lic.No/Date:0910066310<br>08.06.2018
	Decision:Deferred for comments of TE.

Deferred*| |---|---|---|---|---| || HQ File :01/82/050/01517/AM19/|RLA File :09/24/040/00075/AM19/|Lic.No/Date:0910066310 08.06.2018|| ||**Decision:**Deferred for comments of TE.||||

89	Case No.:383/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01840/AM19/	RLA File<br>:05/23/040/00121/AM19/	Lic.No/Date:0510406800<br>08.06.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

90	Case No.:385/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01842/AM19/	RLA File<br>:05/23/040/00501/AM18/	Lic.No/Date:0510406802<br>08.06.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

vide letter dated 10.10.2019.||||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

Case No.:59/13/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066318
:01/82/050/01037/AM19/	:09/24/040/00106/AM19/	11.06.2018

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 91 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:35/13/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066375
:01/82/050/01013/AM19/	:09/24/040/00136/AM19/	22.06.2018

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 92 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

ished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:71/13/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066374
:01/82/050/01049/AM19/	:09/24/040/00134/AM19/	22.06.2018

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 93 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:76/13/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066376
:01/82/050/01054/AM19/	:09/24/040/00135/AM19/	22.06.2018

-|---|---|---|---| |ALC4/2018||LIMITED||ALC4/2020||Rejected| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0910066376||| |:01/82/050/01054/AM19/||:09/24/040/00135/AM19/||22.06.2018|||

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not 94 furnished the information on following deficiencies raised by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 13.02.2020 and Final Reminder on 06.08.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

Case No.:274/10/82-	Party Name:MELOG	Meet No/Date:4/82-	Status:
ALC4/2018	SPECIALITY CHEMICALS	ALC4/2020	Approved
	PVT. LTD.	18.09.2020
HQ File	RLA File	Lic.No/Date:0310821895
:01/82/050/00561/AM19/	:03/95/040/00235/AM19/	25.06.2018

	Export Product	Qty.	Sl.	Import items	Qty.
			No.
	T-2003 (2,2-METHYLEBIS) (4,6-	1 kg	1	2,4-DI-TERTIARY BUTYLPHENOL	1.07 kg
	DI-TERTIARY-BUTYLPHENOL)
RA concerned maytake further necessaryaction asper above decision of NC.

||| ||T-2003 (2,2-METHYLEBIS) (4,6-|1 kg|1|2,4-DI-TERTIARY BUTYLPHENOL|1.07 kg| ||DI-TERTIARY-BUTYLPHENOL)||||| |RA concerned maytake further necessaryaction asper above decision of NC.||||||

Case No.:185/13/82-	Party Name:SPC LIFE	Meet No/Date:4/82-	Status:
ALC4/2018	SCIENCES PVT. LTD.	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:3410044282
:01/82/050/01163/AM19/	:34/24/040/00109/AM19/	26.06.2018

	Case No.:185/13/82-<br>ALC4/2018	Party Name:SPC LIFE<br>SCIENCES PVT. LTD.	Party Name:SPC LIFE<br>SCIENCES PVT. LTD.	Party Name:SPC LIFE<br>SCIENCES PVT. LTD.	Party Name:SPC LIFE<br>SCIENCES PVT. LTD.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:3410044282<br>26.06.2018	Status:<br>Approved
	HQ File<br>:01/82/050/01163/AM19/	RLA File<br>:34/24/040/00109/AM19/
96	<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol.

||| |96| **Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export Product Qty. Sl. No. Import items Qty. 2-N-BUTYL BENZOFURAN. CLEAR LIQUID. 1 kg 1 METHYL-2-BROMO HEXANOATE. CLEAR COLOURLESS LIQUID. 2.316 kg 2 SALICYLALDEHYDE CLEAR COLOURLESS TO LIGHT BROWN LIQUID. 1.35 kg 3 POTASSIUM CARBONATE. WHITE CRYSTALLINE POWDER. 1.00 kg 4 DI METHYL FORMAMIDE. CLEAR COLOURLESS LIQUID. 1.00 kg 5 TOLUNE. CLEAR COLOURLESS LIQUID. 1.00 kg RA concerned may take further necessary action as per above decision of NC.||||||| ||Export Product||Qty.|Sl. No.|Import items||Qty.| || 2-N-BUTYL BENZOFURAN. CLEAR LIQUID.||1 kg|1|METHYL-2-BROMO HEXANOATE. CLEAR COLOURLESS LIQUID.||2.316 kg| |||||2|SALICYLALDEHYDE CLEAR COLOURLESS TO LIGHT BROWN LIQUID.||1.35 kg| |||||3|POTASSIUM CARBONATE. WHITE CRYSTALLINE POWDER.||1.00 kg| |||||4|DI METHYL FORMAMIDE. CLEAR COLOURLESS LIQUID.||1.00 kg| |||||5|TOLUNE. CLEAR COLOURLESS LIQUID.||1.00 kg| ||RA concerned may take further necessary action as||||per above decision of NC.|||

enda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Case No.:117/13/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066395
:01/82/050/01095/AM19/	:09/24/040/00150/AM19/	27.06.2018

	Case No.:117/13/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0910066395<br>27.06.2018	Status:<br>Approved
	HQ File<br>:01/82/050/01095/AM19/	RLA File<br>:09/24/040/00150/AM19/
97	<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol.

||| |97| **Decision:**The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export Product Qty. Sl. No. Import items Qty. [2S,3S,5S]-5-t- butyloxycarbonylamino-2- Amino-3-hydroxy-1,6- diphenylhexane succinate(BDH Succinic Acid RIT) 1 kg 1 1,2-dimethoxyethane(1,2-DME) 4.74 kg 2 SODIUM BORO HYDRIDE 0.45 kg 3 METHANE SULPHONIC ACID 1.50 kg 4 TRIETHANOLAMINE 1.167 kg 5 Di-Tert-Butyl- Di- Carbonate 0.60 kg RA concerned maytake further necessaryaction asper above decision of NC.||||||| || Export Product||Qty.|Sl. No.|Import items||Qty.| ||[2S,3S,5S]-5-t- butyloxycarbonylamino-2- Amino-3-hydroxy-1,6- diphenylhexane succinate(BDH Succinic Acid RIT)||1 kg|1|1,2-dimethoxyethane(1,2-DME)||4.74 kg| |||||2|SODIUM BORO HYDRIDE||0.45 kg| |||||3|METHANE SULPHONIC ACID||1.50 kg| |||||4|TRIETHANOLAMINE||1.167 kg| |||||5|Di-Tert-Butyl- Di- Carbonate||0.60 kg| ||RA concerned maytake further necessaryaction as||||per above decision of NC.|||

in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

98	Case No.:12/15/82-ALC4/2018	Case No.:12/15/82-ALC4/2018	Party Name:AURORE LIFE<br>SCIENCES PRIVATE<br>LIMITED		Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020
	HQ File<br>:01/82/050/01469/AM19/		RLA File<br>:09/24/040/00113/AM19/		Lic.No/Date:0910066403<br>28.06.2018
	Decision:Deferred for comments of TE.

99	Case No.:221/12/82-<br>ALC4/2018	Party Name:IOL<br>CHEMICALS AND<br>PHARMACEUTICALS<br>LIMITED		Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020		Status:<br>Deferred
	HQ File<br>:01/82/050/00848/AM19/	RLA File<br>:30/24/040/00017/AM19/		Lic.No/Date:3010104375<br>29.06.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 28.06.2019 has furnished its reply. Deferred for comments of TE.

e considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 28.06.2019 has furnished its reply. Deferred for comments of TE.|||||||

100	<br>Case No.:417/15/82-<br>ALC4/2018<br>Party Name:JODAS<br>EXPOIM PVT.LTD<br>Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Status: Deferred<br>HQ File<br>:01/82/050/01874/AM19/<br>RLA File<br>:05/23/040/00167/AM19/<br>Lic.No/Date:0510407069<br>04.07.2018<br>Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.	Party Name:JODAS<br>EXPOIM PVT.LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status: Deferred
		RLA File<br>:05/23/040/00167/AM19/	Lic.No/Date:0510407069<br>04.07.2018

Case No.:418/15/82- Party Name:JODAS Meet No/Date:4/82- Status: Deferred ALC4/2018 EXPOIM PVT.LTD ALC4/2020 18.09.2020 101 HQ File RLA File Lic.No/Date:0510407077 :01/82/050/01875/AM19/ :05/23/040/00163/AM19/ 04.07.2018

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

/AM19/ :05/23/040/00163/AM19/ 04.07.2018

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

102	Case No.:419/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01876/AM19/	RLA File<br>:05/23/040/00164/AM19/	Lic.No/Date:0510407078<br>04.07.2018
	Decision:The Committee considered the case as per agenda and it was observed that<br>issued Show Cause Notice vide letter dated 10.10.2019.			the firm was

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

103	<br>Case No.:389/15/82-<br>ALC4/2018	<br>Case No.:389/15/82-<br>ALC4/2018	Party Name:ATUL LIMITED,	Party Name:ATUL LIMITED,	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020
	<br>HQ File<br>:01/82/050/01846/AM19/		RLA File<br>:08/24/040/00030/AM19/		Lic.No/Date:0810142955<br>04.07.2018
	Decision:Deferred for comments of TE.

104	Case No.:617/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD		<br>Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020		Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02074/AM19/	RLA File<br>:05/23/040/00166/AM19/		Lic.No/Date:0510407070<br>04.07.2018

|| Meet No/Date:4/82- ALC4/2020 18.09.2020||Status: Deferred|| || HQ File :01/82/050/02074/AM19/|RLA File :05/23/040/00166/AM19/||Lic.No/Date:0510407070 04.07.2018|||| ||**Decision:**The Committee considered the case as per agenda and it was observed issued Show Cause Notice vide letter dated 10.10.2019.|||||that the firm was||

105	Case No.:96/12/82-<br>ALC4/2018	Party Name:STERLING<br>AUXILIARIES PVT LTD<br>RLA File<br>:03/95/040/00332/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00723/AM19/		Lic.No/Date:0310822247<br>11.07.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 31.10.2019 has furnished its reply. Deferred for comments of TE.

106	<br>Case No.:46/15/82-ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED<br>RLA File<br>:09/24/040/00181/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01503/AM19/		Lic.No/Date:0910066442<br>11.07.2018
	Decision:Deferred for comments of TE.

Case No.:100/13/82-	Party Name:RA CHEM	Meet No/Date:4/82-	Status:
ALC4/2018	PHARMA LIMITED	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066457
:01/82/050/01078/AM19/	:09/24/040/00188/AM19/	13.07.2018

--|---|---| |ALC4/2018||PHARMA LIMITED||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0910066457||| |:01/82/050/01078/AM19/||:09/24/040/00188/AM19/||13.07.2018|||

Export Product			Qty.	Sl.	Import items			Qty.
				No.
FENOFIBRIC	ACID	DR	200.000 kg	1	FENOFIBRATO	DE	COLINE	76.700 kg
PELLETS 29%					(Choline Fenofibrate)

108	<br>Case No.:189/13/82-<br>ALC4/2018<br> <br> <br>HQ File<br>:01/82/050/01167/AM19/<br> <br>:	Party Name:YASH<br>RASAYAN & CHEMICALS	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
		RLA File<br>34/24/040/00114/AM19/	Lic.No/Date:3410044333<br>16.07.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 11.09.2020 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 11.09.2020 has furnished its reply. Deferred for comments of TE.

he Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 11.09.2020 has furnished its reply. Deferred for comments of TE.

109	Case No.:432/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD<br>RLA File<br>:05/23/040/00183/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01889/AM19/		Lic.No/Date:0510407217<br>17.07.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Case No.:444/15/82-	Party Name:OPTIMUS	Meet No/Date:4/82-	Status:
ALC4/2018	DRUGS PRIVATE LIMITED	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066488
:01/82/050/01901/AM19/	:09/24/040/00193/AM19/	19.07.2018

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not furnished the information on following deficiencies raised by NC-3 in its Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 18.03.2020 and Final Reminder on 06.08.2020 :

110

(i) Complete and balanced chemical reactions with % yield on molar basis for each step. (ii) Technical justification alongwith catalogue for LYOPHILIZED ENZYME POWDER. (iii) End-use of the export product.

e and balanced chemical reactions with % yield on molar basis for each step. (ii) Technical justification alongwith catalogue for LYOPHILIZED ENZYME POWDER. (iii) End-use of the export product.**

Case No.:448/15/82-	Party Name:AUROBINDO	Meet No/Date:4/82-	Status:
ALC4/2018	PHARMA LIMITED	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066511
:01/82/050/01905/AM19/	:09/24/040/00200/AM19/	24.07.2018

111

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 11.09.2020 has furnished its reply.

The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 1/82-ALC4/2020 dated 17.04.2020 , followed by Reminder on 23.09.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its 4.07 application, failing which the case will be rejected.

cy Circular No. 23/2015-20, dated 15.05.2019.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its 4.07 application, failing which the case will be rejected.

112	Case No.:239/13/82-<br>ALC4/2018	Party Name:KEVA<br>FRAGRANCES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01217/AM19/	RLA File<br>:03/94/040/00390/AM19/	Lic.No/Date:0310822723<br>31.07.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 21.09.2020 has furnished its reply.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 21.09.2020 has furnished its reply.

Case No.:460/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710113686
:01/82/050/01917/AM19/	:07/24/040/00087/AM19/	06.08.2018

113 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

114	Case No.:172/13/82-<br>ALC4/2018	Party Name:TIDE<br>INDUSTRIES	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01150/AM19/	RLA File<br>:34/24/040/00094/AM19/	Lic.No/Date:3410044399<br>08.08.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 01.11.2019 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 01.11.2019 has furnished its reply. Deferred for comments of TE.

Case No.:134/13/82-	Party Name:YASHO	Meet No/Date:4/82-	Status:
ALC4/2018	INDUSTRIES LIMITED	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0310822942
:01/82/050/01112/AM19/	:03/95/040/00445/AM19/	09.08.2018

115 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was observed that the reply furnished by the firm vide letter dated 24.10.2019 was not proper.

In view of above, the Committee decided to call for following information from the firm:

(i) Chemical reaction with stoichiometric balance.

firm vide letter dated 24.10.2019 was not proper.

In view of above, the Committee decided to call for following information from the firm:

(i) Chemical reaction with stoichiometric balance.

116	Case No.:326/13/82-<br>ALC4/2018	Party Name:BALAJI<br>AMINES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01304/AM19/	RLA File<br>:31/83/040/00082/AM19/	Lic.No/Date:3110067147<br>20.08.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 26.11.2019 has furnished its reply. Deferred for comments of TE.

Case No.:470/15/82- Party Name:JODAS EXPOIM Meet No/Date:4/82- Status: ALC4/2018 PVT.LTD ALC4/2020 Deferred 18.09.2020 117 HQ File RLA File Lic.No/Date:0510407550 :01/82/050/01927/AM19/ :05/23/040/00232/AM19/ 20.08.2018

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

Case No.:471/15/82- Party Name:JODAS EXPOIM Meet No/Date:4/82- Status: ALC4/2018 PVT.LTD ALC4/2020 Deferred 18.09.2020 118 HQ File RLA File Lic.No/Date:0510407551 :01/82/050/01928/AM19/ :05/23/040/00231/AM19/ 20.08.2018

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

/AM19/ :05/23/040/00231/AM19/ 20.08.2018

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

Case No.:472/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710113733
:01/82/050/01929/AM19/	:07/24/040/00131/AM19/	20.08.2018

119 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

|120|Case No.:142/13/82- ALC4/2018|Party Name:PALADIN PAINTS AND CHEMICALS PVT.

20** and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

120	Case No.:142/13/82-<br>ALC4/2018	Party Name:PALADIN<br>PAINTS AND CHEMICALS<br>PVT. LTD.,	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Rejected
	HQ File<br>:01/82/050/01120/AM19/	RLA File<br>:03/95/040/00456/AM19/	Lic.No/Date:0310823254<br>24.08.2018
	<br>Decision:The Committee considered the case as per Agenda and it was noted that the firm still has not<br>furnished the information on following deficiencies raised by NC-3 in its Meeting No.9/82-ALC4/2019<br>dated 18.10.2019,followed by Reminder on09.12.2019and Final Reminder on18.03.2020:<br>(i)<br>Complete 4E with all technical details i.e chemistry, molecular weight,<br>stoichiometric reaction and % of yield on molar basis at every stage.<br>Hence, the Committee decided torejectthe case.<br>RA concerned may take further necessary action as per above decision of NC.

Case No.:209/13/82-	Party Name:DEEPAK	Meet No/Date:4/82-	Status:
ALC4/2018	NOVOCHEM	ALC4/2020	Rejected
	TECHNOLOGIES LTD	18.09.2020
HQ File	RLA File	Lic.No/Date:3110067162
:01/82/050/01187/AM19/	:31/83/040/00081/AM19/	24.08.2018

| |ALC4/2018||NOVOCHEM||ALC4/2020||Rejected| |||TECHNOLOGIES LTD||18.09.2020||| |HQ File||RLA File||Lic.No/Date:3110067162||| |:01/82/050/01187/AM19/||:31/83/040/00081/AM19/||24.08.2018|||

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not furnished the information on following deficiencies raised by NC-3 in its Meeting No. 9/82-ALC4/2019 121 dated 18.10.2019, followed by Reminder on 09.12.2019 and Final Reminder on 19.03.2020 :

(i) Catalogue of OCP. (ii) Certificate of Analysis (CoA) of OCP. (iii) Percentage yield on molar basis.

Case No.:475/15/82-	Party Name:WINTAC	Meet No/Date:4/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Rejected
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710113754
:01/82/050/01932/AM19/	:07/24/040/00098/AM19/	24.08.2018

122 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020, followed by Reminder on 21.02.2020 and Final Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

123	Case No.:368/13/82-<br>ALC4/2018	Party Name:DANOPHARM<br>CHEMICALS PRIVATE LTD.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01346/AM19/	RLA File<br>:03/94/040/00340/AM19/	Lic.No/Date:0310823354<br>28.08.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 28.11.2019 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 28.11.2019 has furnished its reply. Deferred for comments of TE.

124	Case No.:369/13/82-<br>ALC4/2018	Party Name:DANOPHARM<br>CHEMICALS PRIVATE<br>LTD.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01347/AM19/	RLA File<br>:03/94/040/00413/AM19/	Lic.No/Date:0310823358<br>28.08.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 28.11.2019 has furnished its reply. Deferred for comments of TE.

ttee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 28.11.2019 has furnished its reply. Deferred for comments of TE.||||

Case No.:35/15/82-	Party Name:AUROBINDO	Meet No/Date:4/82-	Status:
ALC4/2018	PHARMA LIMITED	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066604
:01/82/050/01492/AM19/	:09/24/040/00249/AM19/	29.08.2018

	Case No.:35/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved	Status:<br>Approved
	HQ File<br>:01/82/050/01492/AM19/	RLA File<br>:09/24/040/00249/AM19/				Lic.No/Date:0910066604<br>29.08.2018
125	Decision:The Committee considered case as<br>was decided to ratify the ad-hoc input output nor<br>as applied by firm whichever is lower:				per agenda in the presence of the technical experts and it<br>ms under para 4.07 of HBP Vol.

case as was decided to ratify the ad-hoc input output nor as applied by firm whichever is lower:||||per agenda in the presence of the technical experts and it ms under para 4.07 of HBP Vol. I as per details below or|||| ||Export Product||Qty.|Sl. No.|Import items|||Qty.| ||ROSUVASTATIN CALCIUM||1 kg|1|Pyrimidine carboxaldehyde|||1.26 kg| |||||2|Activated Carbon(Carbon Enoanticromos)|||0.100 kg| |||||3|Diisopropyl Azodicarboxylate(DIAD)|||1.128 kg| |||||4|Isopropyl alcohol(IPA)|||2.15 kg| |||||5|Methanol(Methyl Alcohol)|||9.93 kg| |||||6|Methylene chloride(MDC)|||4.81 kg| |||||7|Potassium carbonate(Anhydrous)|||0.35 kg| |||||8|(4R-Cis)-6-[(Acetyloxy)Methyl]-2,2- Dimethyl-1,3-Dioxane-4-Acetic Acid 1,1- Dimethylethyl Ester|||1.53 kg| |||||9|Tetrahydrofuran(THF)|||11.80 kg| |||||10|Triphenylphosphine(TPP)|||1.464 kg| ||RA concerned may take further necessary|||action a|s per above decision of NC.||||

Case No.:492/15/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066600
:01/82/050/01949/AM19/	:09/24/040/00245/AM19/	29.08.2018

in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or 126 as applied by firm whichever is lower:

Export Product	Qty.	Sl.<br>No.	Import items	Qty.
(3R,3aS,6aR)-Hexahydrofuro[2,3-<br>b]furan-3-ol(BIS-IV)	1 kg	1	2,3-dihydrofuran	1.05 kg
		2	Sodium borohydride	0.72 kg

127	Case No.:84/13/82-ALC4/2018	Party Name:SRINI<br>PHARMACEUTICALS<br>PRIVATE LIMITED<br>RLA File<br>:09/24/040/00251/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br> <br><br>Lic.No/Date:0910066620<br>03.09.2018	Status:<br>Deferred
	HQ File<br>:01/82/050/01062/AM19/
	Decision:Deferred for comments of TE.

128	<br>Case No.:502/15/82-<br>ALC4/2018	Party Name:SUVEN LIFE<br>SCIENCES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0910066621<br>03.09.2018	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01959/AM19/	RLA File<br>:09/24/040/00260/AM19/
	Decision:Deferred for comments of TE.

129	<br>Case No.:435/13/82-<br>ALC4/2018	Party Name:DCM SHRIRAM<br>INDUSTRIES LTD,	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0510407689<br>05.09.2018	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01413/AM19/	RLA File<br>:05/23/040/00242/AM19/
	Decision:Deferred for comments of TE.

0 Lic.No/Date:0510407689 05.09.2018|Status: Deferred| || HQ File :01/82/050/01413/AM19/|RLA File :05/23/040/00242/AM19/||| ||**Decision:**Deferred for comments of TE.||||

130	Case No.:44/15/82-<br>ALC4/2018	Party Name:DISCOVERY<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01501/AM19/	RLA File<br>:09/24/040/00283/AM19/	Lic.No/Date:0910066631<br>06.09.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 23.09.2020 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 23.09.2020 has furnished its reply. Deferred for comments of TE.

Case No.:429/13/82-	Party Name:CADILA	Meet No/Date:4/82-	Status:
ALC4/2018	HEALTHCARE LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0810143413
:01/82/050/01407/AM19/	:08/24/040/00131/AM19/	07.09.2018

--|---|---| |ALC4/2018||HEALTHCARE LTD||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0810143413||| |:01/82/050/01407/AM19/||:08/24/040/00131/AM19/||07.09.2018|||

	Case No.:429/13/82-<br>ALC4/2018	Case No.:429/13/82-<br>ALC4/2018	Case No.:429/13/82-<br>ALC4/2018	Party Name:CADILA<br>HEALTHCARE LTD	Party Name:CADILA<br>HEALTHCARE LTD	Party Name:CADILA<br>HEALTHCARE LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br> <br><br>Lic.No/Date:0810143413<br>07.09.2018	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br> <br><br>Lic.No/Date:0810143413<br>07.09.2018	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br> <br><br>Lic.No/Date:0810143413<br>07.09.2018	Status:<br>Approved
	HQ File<br>:01/82/050/01407/AM19/			RLA File<br>:08/24/040/00131/AM19/
131	<br>Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or<br>as applied by firm whichever is lower:<br>Export Product<br>Qty.<br>Sl.<br>No.<br>Import Items<br>Qty.

to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export Product Qty. Sl. No. Import Items Qty. allowed in mg for 1 Number Tablet 12.5mg 25.0mg 50.0mg PROMETHAZINE HYDROCHLORIDE TABLETS USP 12.5 MG / 25 MG / 50 MG Tablet 1 Number Tablet 1 PROMETHAZINE HYDROCHLORIDE USP 12.75 mg 25.50 mg 51.0 mg 2 HYDROXY PROPYL CELLULOSE (LOW SUBSTITUT) 2.00 mg 4.00 mg 8.00 mg 3 HYDROXYPROPYL CELLULOSE NF (KLUCEL LF) 4.00 mg 8.00 mg 16.00 mg 4 LACTOSE MONOHYDRATE NF/PH.EU 81.00 mg 162.00 mg 324.00 mg 5 MAGNESIUM STEARATE PH.E/NF/JP 0.50 mg 1.00 mg 2.00 mg RA concerned maytake further necessaryaction asper above decision of NC.|||||||||| |||Export Product|Qty.||Sl. No.|Import Items||Qty. allowed in mg for 1 Number Tablet||| |||||||||12.5mg|25.0mg|50.0mg| |||PROMETHAZINE HYDROCHLORIDE TABLETS USP 12.5 MG / 25 MG / 50 MG Tablet|1 Number Tablet||1|PROMETHAZINE HYDROCHLORIDE USP||12.75 mg|25.50 mg|51.0 mg| ||||||2|HYDROXY PROPYL CELLULOSE (LOW SUBSTITUT)||2.00 mg|4.00 mg|8.00 mg| ||||||3|HYDROXYPROPYL CELLULOSE NF (KLUCEL LF)||4.00 mg|8.00 mg|16.00 mg| ||||||4|LACTOSE MONOHYDRATE NF/PH.EU||81.00 mg|162.00 mg|324.00 mg| ||||||5|MAGNESIUM STEARATE PH.E/NF/JP||0.50 mg|1.00 mg|2.00 mg| ||||||||||||

4.00 mg|8.00 mg|16.00 mg| ||||||4|LACTOSE MONOHYDRATE NF/PH.EU||81.00 mg|162.00 mg|324.00 mg| ||||||5|MAGNESIUM STEARATE PH.E/NF/JP||0.50 mg|1.00 mg|2.00 mg| ||||||||||||

Case No.:40/15/82-	Party Name:INCHEM	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES PRIVATE	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0910066657
:01/82/050/01497/AM19/	:09/24/040/00230/AM19/	11.09.2018

Export Product	Qty.	Sl.	Import items	Qty.
		No.
4 Amino 3,5 Di chloroalpha ( trimethyl	1 kg	1	4 – Nitroacetophenone	1.32 kg
)methyl amino ) methyl benzene methanol
hcl(Clenbuterol HCL)

Case No.:41/15/82-	Party Name:INCHEM	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES PRIVATE	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0910066658
:01/82/050/01498/AM19/	:09/24/040/00261/AM19/	11.09.2018

in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or 133 as applied by firm whichever is lower:

Export Product	Export Product			Qty.	Sl.	Import items	Qty.
					No.
4 Amino	3,5 Di	chloroalpha (	trimethyl	1 kg	1	4-Amino aceto phenone	1.32 kg
)methyl	amino	<br>)<br>methyl	benzene
methanol	hcl(Clenbuterol HCL)

	Case No.:17/7/82-ALC4/2019	Party Name:GLOBAL	Meet No/Date:4/82-	Status:
		CALCIUM PRIVATE	ALC4/2020	Deferred
		LIMITED	18.09.2020
134	HQ File	RLA File	Lic.No/Date:0710113843
	:01/82/050/00512/AM20/	:07/24/040/00144/AM19/	12.09.2018
	Decision:Deferred for comments of TE.

	Case No.:400/13/82-	Party Name:J.B.	Meet No/Date:4/82-	Status:
	ALC4/2018	CHEMICALS &	ALC4/2020	Deferred
		PHARMACEUTICALS	18.09.2020
135		LIMITED
	HQ File	RLA File	Lic.No/Date:0310823779
	:01/82/050/01378/AM19/	:03/94/040/00504/AM19/	17.09.2018
	Decision:Deferred for comments of TE.

136	<br>Case No.:519/15/82-<br>ALC4/2018<br>Party Name:SUVEN LIFE<br>SCIENCES LIMITED<br>HQ File<br>:01/82/050/01976/AM19/<br>RLA File<br>:09/24/040/00288/AM19/<br>Decision:Deferred for comments of TE.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0910066679<br>18.09.2018	Status:<br>Deferred<br>

40/00288/AM19/ **Decision:**Deferred for comments of TE.|Meet No/Date:4/82- ALC4/2020 18.09.2020 Lic.No/Date:0910066679 18.09.2018|Status: Deferred | |---|---|---|---|

Case No.:525/15/82-	Party Name:SHILPA	Meet No/Date:4/82-	Status:
ALC4/2018	MEDICARE LIMITED	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0710113890
:01/82/050/01982/AM19/	:07/24/040/00164/AM19/	25.09.2018

137 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 1/82-ALC4/2020 dated 17.04.2020 , followed by Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its 4.07 application, failing which the case will be rejected.

138	Case No.:176/13/82-<br>ALC4/2018	Party Name:VOVANTIS<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01154/AM19/	RLA File<br>:34/24/040/00145/AM19/	Lic.No/Date:3410044518<br>26.09.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 03.04.2020 has furnished its reply. Deferred for comments of TE.

ttee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 03.04.2020 has furnished its reply. Deferred for comments of TE.||||

139	Case No.:213/13/82-<br>ALC4/2018	Party Name:DEEPAK<br>NOVOCHEM<br>TECHNOLOGIES LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Rejected
	HQ File<br>:01/82/050/01191/AM19/	RLA File<br>:31/83/040/00094/AM19/	Lic.No/Date:3110067177<br>26.09.2018
	<br>Decision:The Committee considered the case as per Agenda and it was noted that the firm still has not<br>furnished the information on following deficiencies raised by NC-3 in its Meeting No.9/82-ALC4/2019<br>dated 18.10.2019,followed by Reminder on09.12.2019and Final Reminder on19.03.2020:<br>(i)<br>Exact chemical name of the export product<br>Hence, the Committee decided torejectthe case.<br>RA concerned maytake further necessaryaction asper above decision of NC.

140	<br>Case No.:534/15/82-<br>ALC4/2018	Party Name:YASH RASAYAN<br>& CHEMICALS<br>RLA File<br>:34/24/040/00184/AM19/	<br>Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:3410044523<br>26.09.2018	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01991/AM19/
	Decision:Deferred for comments of TE.

br>18.09.2020 Lic.No/Date:3410044523 26.09.2018|Status: Deferred| |---|---|---|---|---| || HQ File :01/82/050/01991/AM19/|||| ||**Decision:**Deferred for comments of TE.||||

141	<br>Case No.:536/15/82-<br>ALC4/2018	Party Name:YASH RASAYAN<br>& CHEMICALS	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01993/AM19/	RLA File<br>:34/24/040/00185/AM19/	Lic.No/Date:3410044524<br>26.09.2018
	Decision:Deferred for comments of TE.

142	<br>Case No.:112/13/82-<br>ALC4/2018	Party Name:VARAHI<br>PHARMA PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01090/AM19/	RLA File<br>:66/24/040/00004/AM19/	Lic.No/Date:6610000013<br>03.10.2018
	Decision:Deferred for comments of TE.

143	Case No.:612/15/82-<br>ALC4/2018	Party Name:MANGALAM<br>ORGANICS LIMITED<br>(FORMERLY DUJODWALA	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02069/AM19/	RLA File<br>:03/95/040/00560/AM19/	Lic.No/Date:0310824148<br>03.10.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 04.11.2019 has furnished its reply. Deferred for comments of TE.

considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 04.11.2019 has furnished its reply. Deferred for comments of TE.||||

Case No.:52/13/82-	Party Name:S V LABS PVT	Meet No/Date:4/82-	Status:
ALC4/2018	LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066711
:01/82/050/01030/AM19/	:09/24/040/00301/AM19/	04.10.2018

	Case No.:52/13/82-<br>ALC4/2018	Case No.:52/13/82-<br>ALC4/2018	Party Name:S V LABS PVT<br>LTD	Party Name:S V LABS PVT<br>LTD	Party Name:S V LABS PVT<br>LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved<br>
	HQ File<br>:01/82/050/01030/AM19/		RLA File<br>:09/24/040/00301/AM19/			Lic.No/Date:0910066711<br>04.10.2018
144	Decision:The Committee considered case<br>was decided to ratify the ad-hoc input output<br>as applied by firm whichever is lower:				as per agenda in the presence of the technical experts and it<br>norms under para 4.07 of HBP Vol. I as per details below or
	Export Product	Qty.		Sl.<br>No.	Import items		Qty.
	FCE (SA)	1 kg		1	5- Flouro Cytosine		0.44 kg
				2	Glyoxyllic acid(50 %)		0.62 kg
				3	2,5-DIHYDROXY-1,4 DITHANE(DIOL)		0.28 kg
				4	HEXAMETHYL DISILAZANE(HMDS)		0.29 kg
				5	Triphosgene		0.40 kg
				6	Methylene Dichloride(MDC)		3.00 kg
	RA concerned may take further necessary action as per above decision of NC.

HEXAMETHYL DISILAZANE(HMDS)|||0.29 kg| |||||5|Triphosgene|||0.40 kg| |||||6|Methylene Dichloride(MDC)|||3.00 kg| ||RA concerned may take further necessary action as per above decision of NC.||||||||

Case No.:562/15/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066712
:01/82/050/02019/AM19/	:09/24/040/00302/AM19/	04.10.2018

	Case No.:562/15/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved
	HQ File<br>:01/82/050/02019/AM19/	RLA File<br>:09/24/040/00302/AM19/				Lic.No/Date:0910066712<br>04.10.2018
145	Decision:The Committee considered case as per agenda in<br>was decided to ratify the ad-hoc input output norms under para<br>as applied by firm whichever is lower:
	Export Product		Qty.	Sl.<br>No.	Import items		Qty.
	2S,3S,5S)-2-AMINO-3-<br>HYDROXY-5-(1-TETRA-<br>HYDRO PYRIMID-2-ONLY)-<br>3-METHYL<br>BUTANOYL)<br>AMINO-1,6-DIPHENYL<br>HEXANE-S-PYRO<br>GLUTAMATE(THP)		1 kg	1	L-PHENYLALANINE		0.473 kg
				2	1,2 DIMETHOXYETHANE		6.74 kg
				3	SODIUM BORO HYDRIDE		0.406 kg
				4	METHANE SULPHONIC ACID		1.57 kg
				5	L- VALINE		0.630 kg
				6	N,N- CARBONYL DIMIDAZOLE		0.443 kg
				7	L-PYROGLUTAMIC ACID		0.295 kg

and all technical details starting from OCP** 50. Hence, the Committee decided torejectthe case. RA concerned maytake further necessaryaction asper above decision of NC.||||

169	<br>Case No.:183/13/82-<br>ALC4/2018	Party Name:PHAROSE<br>REMEDIES LTD.<br>RLA File<br>:30/24/040/00032/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:3010104485<br>31.10.2018	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01161/AM19/
	Decision:Deferred for comments of TE.

Case No.:614/15/82-	Party Name:SUVEN LIFE	Meet No/Date:4/82-	Status:
ALC4/2018	SCIENCES LIMITED	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066814
:01/82/050/02071/AM19/	:09/24/040/00360/AM19/	08.11.2018

Decision: The Committee considered case as per agenda in the presence of the technical experts and it 170 was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export Product<br>2-CHLORO-5-IODOBENZOIC ACID	Qty.	Sl.<br>No.	Import items	Qty.
	1 kg	1	ETHYL ANTHRANILATE	0.764 kg

ils below or as applied by firm whichever is lower:

Export Product<br>2-CHLORO-5-IODOBENZOIC ACID	Qty.	Sl.<br>No.	Import items	Qty.
	1 kg	1	ETHYL ANTHRANILATE	0.764 kg

171	<br>Case No.:111/15/82-<br>ALC4/2018	Party Name:PUNJAB<br>CHEMICALS AND CROP<br>PROTECTION LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0310824946<br>12.11.2018	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01568/AM19/	RLA File<br>:03/95/040/00709/AM19/
	Decision:Deferred for comments of TE.

Case No.:616/15/82-	Party Name:VIVIMED LIFE	Meet No/Date:4/82-	Status:
ALC4/2018	SCIENCES PRIVATE	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0910066821
:01/82/050/02073/AM19/	:09/24/040/00387/AM19/	12.11.2018

	Case No.:616/15/82-<br>ALC4/2018	Party Name:VIVIMED LIFE<br>SCIENCES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved
	HQ File<br>:01/82/050/02073/AM19/	RLA File<br>:09/24/040/00387/AM19/	Lic.No/Date:0910066821<br>12.11.2018
172	Decision:The Committee considered the case as per agenda in the presence of Technical Experts in<br>light<br>of<br>the<br>earlier<br>decision<br>taken<br>by<br>NC<br>in<br>its<br>Meeting<br>No.<br>3/82-ALC4/2020<br>, dated 07.08.2020 for advance authorization No. 0910067741 dated 03.07.2019, it was decided to ratify<br>the ad-hoc input output norms under para 4.07 of HBP Vol.

Meeting No. 3/82-ALC4/2020 , dated 07.08.2020 for advance authorization No. 0910067741 dated 03.07.2019, it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Sl. No Export Product Qty. Sl. No. Import items Qty. 1 Amlodipine Besylate Tablets USP - 2.5Mg - 500 s 75000000 Number 1 Amlodipine Besylate 260.25 kg 2 Anhydrous dibasic calcium Phospahte (A- TAB) 900.00 kg 3 Microcrystalline Cellulose 6002.25 kg 4 Sodium Starch Glycolate 150.00 kg 5 Colloidal Silicon Dioxide(Aerosil 200) 37.50 kg 6 Stearic Acid (Hystrene 5016 FG) 112.50 kg 7 Magnesium Stearate 37.50 kg 2 Amlodipine Besylate Tablets USP - 5 Mg - 1000 s 180000000 Number 1 Amlodipine Besylate 1167.54 kg 2 Anhydrous dibasic calcium Phospahte (A- TAB) 4039.20 kg 3 Microcrystalline Cellulose 26938.56 kg 4 Sodium Starch Glycolate 673.20 kg 5 Colloidal Silicon Dioxide(Aerosil 200) 168.30 kg 6 Stearic Acid (Hystrene 5016 FG) 504.90 kg 7 Magnesium Stearate 168.30 kg 3 Amlodipine Besylate Tablets USP - 10Mg - 1000 s 135000000 Number 1 Amlodipine Besylate 1167.54 kg 2 Anhydrous dibasic calcium Phospahte (A- TAB) 4039.20 kg 3 Microcrystalline Cellulose 26938.56 kg 4 Sodium Starch Glycolate 673.20 kg 5 Colloidal Silicon Dioxi

ydrous dibasic calcium Phospahte (A- TAB) 4039.20 kg 3 Microcrystalline Cellulose 26938.56 kg 4 Sodium Starch Glycolate 673.20 kg 5 Colloidal Silicon Dioxide(Aerosil 200) 168.30 kg 6 Stearic Acid (Hystrene 5016 FG) 504.90 kg 7 Magnesium Stearate 168.30 kg RA concerned maytake further necessaryaction asper above decision of NC.||||

Decision: The Committee considered the case as per agenda in the presence of Technical Experts in light of the earlier decision taken by NC in its Meeting No. 3/82-ALC4/2020 , dated 07.08.2020 for advance authorization No. 0910067741 dated 03.07.2019, it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:


173	Case No.:87/15/82-ALC4/2018	Party Name:DEEPAK<br>NITRITE LIMITED	Meet No/Date:4/82-<br>ALC4/2020	Status:<br>Deferred
	<br>HQ File		18.09.2020
		RLA File	Lic.No/Date:3410044685
	:01/82/050/01544/AM19/<br>:34/24/040/00267/AM19/<br>13.11.2018<br>Decision:The Committee considered the case as per agenda in the presence of technical<br>	:34/24/040/00267/AM19/	13.11.2018
				experts and it<br>
	was noted that the firm vide e-mail dated 03.09.2020 has furnished its reply. Deferred for comments of TE.

sence of technical |:34/24/040/00267/AM19/|13.11.2018|| |||||experts and it | ||was noted that the firm vide e-mail dated 03.09.2020 has furnished its reply. Deferred for comments of TE.||||

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 03.09.2020 has furnished its reply. Deferred for comments of TE.

	Case No.:623/15/82-		Party Name:VINS		Meet No/Date:4/82-		Status:
	ALC4/2018		BIOPRODUCTS LTD`		ALC4/2020		Deferred
					18.09.2020
	HQ File		RLA File		Lic.No/Date:0910066851
174	:01/82/050/02080/AM19/		:09/24/040/00363/AM19/		14.11.2018
	Decision:The Committee	considered the case as per agenda in the presence of technical experts and it
	was noted that the firm vide	e-mail dated 26.03.2020 has furnished its reply. It was decided				to forward a
	copy of 4.07 application alongwith a copy of reply received from			firm to Department of Biotechnology for
	obtainingtheir comments.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 26.03.2020 has furnished its reply. It was decided to forward a copy of 4.07 application alongwith a copy of reply received from firm to Department of Biotechnology for obtaining their comments.

ed 26.03.2020 has furnished its reply. It was decided to forward a copy of 4.07 application alongwith a copy of reply received from firm to Department of Biotechnology for obtaining their comments.

	Case No.:627/15/82-	Party Name:AUROBINDO	Meet No/Date:4/82-	Status:
	ALC4/2018	PHARMA LIMITED	ALC4/2020	Deferred
			18.09.2020
175	HQ File	RLA File	Lic.No/Date:0910066853
	:01/82/050/02084/AM19/	:09/24/040/00382/AM19/	15.11.2018
	Decision:Deferred for comments of TE.

	Case No.:630/15/82-	Party Name:VIVIN DRUGS &	Meet No/Date:4/82-	Status:
	ALC4/2018	PHARMACEUTICALS	ALC4/2020	Deferred
		LIMITED	18.09.2020
176	HQ File	RLA File	Lic.No/Date:0910066856
	:01/82/050/02087/AM19/	:09/24/040/00391/AM19/	15.11.2018
	Decision:Deferred for comments of TE.


177	<br>Case No.:2/15/82-ALC4/2018 <br>HQ File	Party Name:DEEPAK<br>NITRITE LIMITED	Meet No/Date:4/82-<br>ALC4/2020	Status:<br>Deferred
			<br>18.09.2020
		RLA File	LicNo/Date:3410044710
	<br> <br>:01/82/050/01459/AM19/<br> <br>:34/24/040/00254/AM19/<br>.<br>20.11.2018<br>Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 13.08.2020 has furnished its reply. Deferred for comments of TE.	<br>:34/24/040/00254/AM19/	.<br>20.11.2018

e of technical experts and it was noted that the firm vide e-mail dated 13.08.2020 has furnished its reply. Deferred for comments of TE.| :34/24/040/00254/AM19/|. 20.11.2018|| ||||||

Case No.:85/15/82-ALC4/2018	Party Name:DEEPAK<br>NITRITE LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
<br>HQ File<br>:01/82/050/01542/AM19/	RLA File<br>:34/24/040/00255/AM19/	Lic.No/Date:3410044711<br>20.11.2018
Decision:The Committee considered the case as per agenda i<br>		n the presence of technical<br>	experts and it<br>
was noted that the firm vide e-mail dated 13.08.2020 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 13.08.2020 has furnished its reply. Deferred for comments of TE.

	Case No.:86/15/82-ALC4/2018Party Name:DEEPAK	Meet No/Date:4/82-		Status:
	NITRITE LIMITED	ALC4/2020		Deferred
		18.09.2020
179	HQ File<br>RLA File	Lic.No/Date:3410044712
	:01/82/050/01543/AM19/<br>:34/24/040/00256/AM19/	20.11.2018
	Decision:The Committee considered the case as per agenda in the presence of technical		experts and it
	was noted that the firm vide e-mail dated 13.08.2020 has furnished its reply. Deferred for comments of TE.

considered the case as per agenda in the presence of technical|||experts and it|| |||was noted that the firm vide e-mail dated 13.08.2020 has furnished its reply. Deferred for comments of TE.|||||

	Case No.:638/15/82-	Party Name:AUROBINDO	Meet No/Date:4/82-	Status:
	ALC4/2018	PHARMA LIMITED	ALC4/2020	Deferred
			18.09.2020
180	HQ File	RLA File	Lic.No/Date:0910066874
	:01/82/050/02095/AM19/	:09/24/040/00386/AM19/	20.11.2018
	Decision:Deferred for comments of TE.

	Case No.:639/15/82-	Party Name:CADILA	Meet No/Date:4/82-	Status:
	ALC4/2018	HEALTHCARE LTD	ALC4/2020	Deferred
			18.09.2020
181	HQ File	RLA File	Lic.No/Date:0810143923
	:01/82/050/02096/AM19/	:08/24/040/00187/AM19/	20.11.2018
	Decision:Deferred for comments of TE.

rred**| |||||||18.09.2020||| |181||HQ File||RLA File||Lic.No/Date:0810143923||| |||:01/82/050/02096/AM19/||:08/24/040/00187/AM19/||20.11.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:463/13/82-	Party Name:INDIA GLYCOLS		Meet No/Date:4/82-		Status:
	ALC4/2018	LTD.,		ALC4/2020		Deferred
				18.09.2020
182	HQ File	RLA File		Lic.No/Date:0510408634
	:01/82/050/01441/AM19/	:05/23/040/00359/AM19/		26.11.2018
	Decision:The Committee considered the case as per agenda in the presence of technical				experts and it
	was noted that the firm vide letter dated 28.09.2020 has furnished		its reply. Deferred for comments of TE.

183	<br>Case No.:649/15/82-<br>ALC4/2018	Party Name:GLOBE<br>TROTTERS PVT LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02106/AM19/	RLA File<br>:03/94/040/00713/AM19/	Lic.No/Date:0310825212<br>26.11.2018
	Decision:Deferred for comments of TE.

184	<br>Case No.:659/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02116/AM19/	RLA File<br>:09/24/040/00410/AM19/	Lic.No/Date:0910066905<br>28.11.2018
	Decision:Deferred for comments of TE.

Deferred*| |---|---|---|---|---| || HQ File :01/82/050/02116/AM19/|RLA File :09/24/040/00410/AM19/|Lic.No/Date:0910066905 28.11.2018|| ||**Decision:**Deferred for comments of TE.||||

185	<br>Case No.:664/15/82-<br>ALC4/2018<br>Party<br>Name:SMILAX LABORATORI<br>ES LIMITED<br>HQ File<br>:01/82/050/02121/AM19/<br>RLA File<br>:09/24/040/00358/AM19/<br>Decision:Deferred for comments of TE.	Party<br>Name:SMILAX LABORATORI<br>ES LIMITED	Party<br>Name:SMILAX LABORATORI<br>ES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
		RLA File<br>:09/24/040/00358/AM19/		Lic.No/Date:0910066915<br>28.11.2018


186	Case No.:669/15/82-<br>ALC4/2018		Party Name:VERVE HUMAN<br>CARE LABORATORIES		Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02126/AM19/		RLA File<br>:61/24/040/00012/AM19/		Lic.No/Date:6110001560<br>28.11.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 09.08.2019 has furnished its reply. Deferred for comments of TE.

e considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 09.08.2019 has furnished its reply. Deferred for comments of TE.|||||||

187	<br>Case No.:670/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02127/AM19/	RLA File<br>:61/24/040/00013/AM19/	Lic.No/Date:6110001561<br>28.11.2018
	Decision:Deferred for comments of TE.

188	<br>Case No.:671/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02128/AM19/	RLA File<br>:61/24/040/00014/AM19/	Lic.No/Date:6110001562<br>28.11.2018
	Decision:Deferred for comments of TE.

189	<br>Case No.:672/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02129/AM19/	RLA File<br>:61/24/040/00015/AM19/	Lic.No/Date:6110001563<br>28.11.2018
	Decision:Deferred for comments of TE.

Deferred*| |---|---|---|---|---| || HQ File :01/82/050/02129/AM19/|RLA File :61/24/040/00015/AM19/|Lic.No/Date:6110001563 28.11.2018|| ||**Decision:**Deferred for comments of TE.||||

190	<br>Case No.:673/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02130/AM19/	Party Name:VERVE HUMAN<br>CARE LABORATORIES<br> <br> <br> <br>RLA File<br>:61/24/040/00018/AM19/<br> <br>	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
			Lic.No/Date:6110001564<br>28.11.2018
	Decision:Deferred for comments of TE.

191	<br>Case No.:674/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02131/AM19/	RLA File<br>:61/24/040/00017/AM19/	Lic.No/Date:6110001565<br>28.11.2018
	Decision:Deferred for comments of TE.

192	<br>Case No.:675/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02132/AM19/	RLA File<br>:61/24/040/00016/AM19/	Lic.No/Date:6110001566<br>28.11.2018
	Decision:Deferred for comments of TE.

Deferred*| |---|---|---|---|---| || HQ File :01/82/050/02132/AM19/|RLA File :61/24/040/00016/AM19/|Lic.No/Date:6110001566 28.11.2018|| ||**Decision:**Deferred for comments of TE.||||

193	<br>Case No.:668/15/82-<br>ALC4/2018	Party Name:CADILA<br>HEALTHCARE LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02125/AM19/	RLA File<br>:08/24/040/00264/AM19/	Lic.No/Date:0810143988<br>29.11.2018
	Decision:Deferred for comments of TE.

194	<br>Case No.:689/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02146/AM19/	RLA File<br>:09/24/040/00421/AM19/	Lic.No/Date:0910066921<br>29.11.2018
	Decision:Deferred for comments of TE.

195	<br>Case No.:684/15/82-<br>ALC4/2018	Party Name:GLAND<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02141/AM19/	RLA File<br>:09/24/040/00419/AM19/	Lic.No/Date:0910066930<br>03.12.2018
	Decision:Deferred for comments of TE.

196	<br>Case No.:685/15/82-<br>ALC4/2018	Party Name:GLAND<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02142/AM19/	RLA File<br>:09/24/040/00420/AM19/	Lic.No/Date:0910066931<br>03.12.2018
	Decision:Deferred for comments of TE.

Deferred*| |---|---|---|---|---| || HQ File :01/82/050/02142/AM19/|RLA File :09/24/040/00420/AM19/|Lic.No/Date:0910066931 03.12.2018|| ||**Decision:**Deferred for comments of TE.||||

197	Case No.:688/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD<br>RLA File<br>:05/23/040/00385/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0510408748<br>04.12.2018	Status:<br>Deferred<br>
	<br>HQ File<br>:01/82/050/02145/AM19/
	Decision:The Committee considered the case as per agenda and it was observed tha<br>issued Show Cause Notice vide letter dated 10.10.2019.			t the firm was

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

198	<br>Case No.:103/15/82-<br>ALC4/2018	Party Name:STERLING<br>AUXILIARIES PVT LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01560/AM19/	RLA File<br>:03/95/040/00851/AM19/	Lic.No/Date:0310825462<br>05.12.2018
	Decision:Deferred for comments of TE.

Case No.:692/15/82-	Party Name:ORTIN	Meet No/Date:4/82-	Status:
ALC4/2018	LABORATORIES LTD	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066938
:01/82/050/02149/AM19/	:09/24/040/00424/AM19/	05.12.2018

|---|---| |ALC4/2018||LABORATORIES LTD||ALC4/2020||Approved| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0910066938||| |:01/82/050/02149/AM19/||:09/24/040/00424/AM19/||05.12.2018|||

Export Product<br>(3R,3aS,6aR)-Hexahydrofuro[2,3-<br>b]furan-3-ol(BIS-IV)	Qty.	Sl.<br>No.	Import items<br>	Qty.
	1 kg	1	2,3-dihydrofuran<br>	1.05 kg
		2	Sodium borohydride<br>	0.72 kg

200	Case No.:696/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED<br>RLA File<br>:09/24/040/00436/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br> <br>	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02153/AM19/		Lic.No/Date:0910066944<br>05.12.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 19.10.2019 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 19.10.2019 has furnished its reply. Deferred for comments of TE.

he Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 19.10.2019 has furnished its reply. Deferred for comments of TE.

Case No.:773/15/82-	Party Name:LUPIN LIMITED	Meet No/Date:4/82-	Status:
ALC4/2018		ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0310825460
:01/82/050/02230/AM19/	:03/95/040/00902/AM19/	05.12.2018

201 Decision: The firm vide e-mail dated 07.08.2020 has informed that its application for subject Advance Authorization falls under under para 4.18 of HBP Vol. I (Non-Infringing Process) and hence they should be exempted from approval of NC.

The Committee considered the request of firm and it was decided to verify the same from RLA, Mumbai.

202	<br>Case No.:466/13/82-<br>ALC4/2018	Party Name:DCM SHRIRAM<br>INDUSTRIES LTD,	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01444/AM19/	RLA File<br>:05/23/040/00376/AM19/	Lic.No/Date:0510408809<br>06.12.2018
	Decision:Deferred for comments of TE.

203	<br>Case No.:698/15/82-<br>ALC4/2018	Party Name:VISION DRUGS<br>PVT LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02155/AM19/	RLA File<br>:09/24/040/00412/AM19/	Lic.No/Date:0910066949<br>06.12.2018
	Decision:Deferred for comments of TE.

Deferred*| |---|---|---|---|---| || HQ File :01/82/050/02155/AM19/|RLA File :09/24/040/00412/AM19/|Lic.No/Date:0910066949 06.12.2018|| ||**Decision:**Deferred for comments of TE.||||

204	Case No.:700/15/82-<br>ALC4/2018	Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED<br>RLA File<br>:03/94/040/00748/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0310825472<br>06.12.2018	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02157/AM19/
	Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to call for following information from the firm:<br>(i)<br>Copy of DML for both export items.

205	Case No.:185/15/82-<br>ALC4/2018	Party Name:YASHO<br>INDUSTRIES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01642/AM19/	RLA File<br>:03/95/040/00925/AM19/	Lic.No/Date:0310825514<br>07.12.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 24.10.2019 has furnished its reply. Deferred for comments of TE.

he Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 24.10.2019 has furnished its reply. Deferred for comments of TE.

206	<br>Case No.:88/15/82-<br>ALC4/2018	Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED<br>RLA File<br>:03/94/040/00774/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br> <br>	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01545/AM19/		Lic.No/Date:0310825559<br>10.12.2018
	Decision:Deferred for comments of TE.

207	<br>Case No.:715/15/82-<br>ALC4/2018	Party Name:MALLADI<br>DRUGS &<br>PHARMACEUTICALS<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02172/AM19/	RLA File<br>:04/24/040/00143/AM19/	Lic.No/Date:0410164962<br>10.12.2018
	Decision:Deferred for comments of TE.

208	<br>Case No.:139/15/82-<br>ALC4/2018	Party Name:RUBICON<br>RESEARCH PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01596/AM19/	RLA File<br>:03/95/040/00889/AM19/	Lic.No/Date:0310825587<br>11.12.2018
	Decision:Deferred for comments of TE.

.2020|Status: Deferred| || HQ File :01/82/050/01596/AM19/|RLA File :03/95/040/00889/AM19/|Lic.No/Date:0310825587 11.12.2018|| ||**Decision:**Deferred for comments of TE.||||

209	<br>Case No.:711/15/82-<br>ALC4/2018	Party Name:SUVEN LIFE<br>SCIENCES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02168/AM19/	RLA File<br>:09/24/040/00441/AM19/	Lic.No/Date:0910066959<br>11.12.2018
	Decision:Deferred for comments of TE.

210	Case No.:106/15/82-<br>ALC4/2018	Party Name:SONGWON<br>SPECIALTY CHEMICALS<br>INDIA PVT. LTD.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01563/AM19/	RLA File<br>:34/24/040/00294/AM19/	Lic.No/Date:3410044750<br>12.12.2018
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 02.03.2020 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 02.03.2020 has furnished its reply. Deferred for comments of TE.

he Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 02.03.2020 has furnished its reply. Deferred for comments of TE.

211	<br>Case No.:721/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02178/AM19/	RLA File<br>:61/24/040/00020/AM19/	Lic.No/Date:6110001570<br>13.12.2018
	Decision:Deferred for comments of TE.

212	<br>Case No.:726/15/82-<br>ALC4/2018	Party Name:NATCO<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02183/AM19/	RLA File<br>:09/24/040/00417/AM19/	Lic.No/Date:0910066973<br>18.12.2018
	Decision:Deferred for comments of TE.

213	<br>Case No.:727/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status: Deferred
	<br>HQ File<br>:01/82/050/02184/AM19/	RLA File<br>:09/24/040/00443/AM19/	Lic.No/Date:0910066974<br>18.12.2018
	Decision:Deferred for comments of TE.

Case No.:735/15/82-	Party Name:CIPLA LIMITED.	Meet No/Date:4/82-	Status:
ALC4/2018		ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0310825758
:01/82/050/02192/AM19/	:03/94/040/00753/AM19/	18.12.2018
Decision:Deferred for comments of TE.

020||Deferred| |||||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0310825758||| |:01/82/050/02192/AM19/||:03/94/040/00753/AM19/||18.12.2018||| |**Decision:**Deferred for comments of TE.|||||||

	Case No.:736/15/82-	Party Name:AMI ORGANICS	Meet No/Date:4/82-	Status:
	ALC4/2018	LIMITED	ALC4/2020	Deferred
			18.09.2020
215	HQ File	RLA File	Lic.No/Date:5210042870
	:01/82/050/02193/AM19/	:52/24/040/00068/AM19/	18.12.2018
	Decision:Deferred for comments of TE.

	Case No.:99/15/82-ALC4/2018	Party Name:SUN	Meet No/Date:4/82-	Status:
		PHARMACEUTICAL	ALC4/2020	Deferred
		INDUSTRIES LTD.	18.09.2020
216	HQ File	RLA File	Lic.No/Date:0510408988
	:01/82/050/01556/AM19/	:05/24/040/00503/AM19/	19.12.2018
	Decision:Deferred for comments of TE.

	Case No.:738/15/82-	Party Name:VIVIMED LABS	Meet No/Date:4/82-	Status:
	ALC4/2018	LIMITED	ALC4/2020	Deferred
			18.09.2020
217	HQ File	RLA File	Lic.No/Date:0910066983
	:01/82/050/02195/AM19/	:09/24/040/00460/AM19/	19.12.2018
	Decision:Deferred for comments of TE.

rred**| |||||||18.09.2020||| |217||HQ File||RLA File||Lic.No/Date:0910066983||| |||:01/82/050/02195/AM19/||:09/24/040/00460/AM19/||19.12.2018||| |||**Decision:**Deferred for comments of TE.|||||||

Case No.:1025/15/82-	Party Name:ANLON	Meet No/Date:4/82-	Status:
ALC4/2018	HEALTHCARE	ALC4/2020	Deferred
	PRIVATELIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:2410042604
:01/82/050/02482/AM19/	:24/24/040/00044/AM19/	19.12.2018

218 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was decided to call for following information from the firm:

(i) Complete chemical reaction, molecular weight and % yield on molar basis for each step of manufacturing process.

Case No.:742/15/82-	Party Name:BEST VALUE	Meet No/Date:4/82-	Status:
ALC4/2018	CHEM PVT. LTD.	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:3410044774
:01/82/050/02199/AM19/	:34/24/040/00295/AM19/	20.12.2018

Decision: The firm vide e-mail dated 29.01.2020 informed that they had applied for issuance of Advance Authorization under para 4.07 A (self declaration and self ratification) in view of its becoming AEO status holder, but while issuing the subject Advance Authorization, RA inadvertently indicated Advance Licence issued under para 4.7 of HBP 2015-20, for which they had requested RLA,Vadodara to amend the 219 condition sheet of advance authorization to para 4.07 A of HBP Vol. I.

indicated Advance Licence issued under para 4.7 of HBP 2015-20, for which they had requested RLA,Vadodara to amend the 219 condition sheet of advance authorization to para 4.07 A of HBP Vol. I.

RLA, Vadodara was requested vide e-mail dated 23.03.2020 to check and verify whether the subject advance authorization was issued under para 4.07A of HBP Vol. I – Self ratification scheme and whether the firm should be exempted from the approval of NC for the said advance authorization.

The requisite reply is still awaited from RLA, Vadodara.

In view of above, the Committee decided to again issue a Reminder to RLA, Vadodara to check and verify whether the subject advance authorization was issued under para 4.07A of HBP Vol. I – Self ratification scheme.

Case No.:743/15/82-	Party Name:SHUBHLAXMI	Meet No/Date:4/82-	Status:
ALC4/2018	INDUSTRIES	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0810144119
:01/82/050/02200/AM19/	:08/24/040/00267/AM19/	20.12.2018

220 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm still has not furnished the 4.07 application asked for by NC-3 in its Meeting No. 1/82-ALC4/2020 dated 17.04.2020 , followed by Reminder on 07.08.2020 as per Policy Circular No. 23/2015-20, dated 15.05.2019.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its 4.07 application, failing which the case will be rejected.

cy Circular No. 23/2015-20, dated 15.05.2019.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its 4.07 application, failing which the case will be rejected.

Case No.:748/15/82-	Party Name:SPANSULES	Meet No/Date:4/82-	Status:
ALC4/2018	FORMULATIONS	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910066987
:01/82/050/02205/AM19/	:09/24/040/00418/AM19/	20.12.2018

Decision: The Committee considered case as per agenda in the presence of the technical experts and it 221 was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower:

Export Product<br>Ascorbic Acid 85% SR Pellets	Qty.	Sl.<br>No.	Import items	Qty.
	1 kg	1	Ascorbic Acid(Vitamin C)	0.8585 kg

222	<br>Case No.:752/15/82-<br>ALC4/2018	Party Name:ATUL LIMITED,<br>RLA File<br>:08/24/040/00303/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0810144142<br>21.12.2018	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02209/AM19/
	Decision:Deferred for comments of TE.

br>18.09.2020 Lic.No/Date:0810144142 21.12.2018|Status: Deferred| |---|---|---|---|---| || HQ File :01/82/050/02209/AM19/|||| ||**Decision:**Deferred for comments of TE.||||

223	<br>Case No.:925/15/82-<br>ALC4/2018	Party Name:OPTRIX<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02382/AM19/	RLA File<br>:09/24/040/00470/AM19/	Lic.No/Date:0910066998<br>24.12.2018
	Decision:Deferred for comments of TE.

224	<br>Case No.:772/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02229/AM19/	RLA File<br>:09/24/040/00445/AM19/	Lic.No/Date:0910067006<br>31.12.2018
	Decision:Deferred for comments of TE.

225	<br>Case No.:775/15/82-<br>ALC4/2018	Party Name:SUVEN LIFE<br>SCIENCES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02232/AM19/	RLA File<br>:09/24/040/00482/AM19/	Lic.No/Date:0910067014<br>31.12.2018
	Decision:Deferred for comments of TE.

Deferred*| |---|---|---|---|---| || HQ File :01/82/050/02232/AM19/|RLA File :09/24/040/00482/AM19/|Lic.No/Date:0910067014 31.12.2018|| ||**Decision:**Deferred for comments of TE.||||

226	Case No.:788/15/82-<br>ALC4/2018	Party Name:MANKIND<br>PHARMA LTD<br>RLA File<br>:05/24/040/00552/AM19/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0510409149<br>02.01.2019	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02245/AM19/
	Decision:The Committee considered case as per agenda in the presence of the technical experts and it<br>was decided to call for following information from the firm:<br>(i)<br>Copy of DML for three export items.

Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to call for following information from the firm:

227	<br>Case No.:1072/15/82-<br>ALC4/2018	Party Name:MALLADI<br>DRUGS &<br>PHARMACEUTICALS<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	HQ File<br>:01/82/050/02529/AM19/	RLA File<br>:04/24/040/00218/AM19/	Lic.No/Date:0410165065<br>04.01.2019
	Decision:Deferred for comments of TE.

Case No.:109/15/82-	Party Name:U SQUARE	Meet No/Date:4/82-	Status:
ALC4/2018	LIFESCIENCE PRIVATE	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0810144243
:01/82/050/01566/AM19/	:08/24/040/00329/AM19/	07.01.2019

|ALC4/2018||LIFESCIENCE PRIVATE||ALC4/2020||Approved| |||LIMITED||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0810144243||| |:01/82/050/01566/AM19/||:08/24/040/00329/AM19/||07.01.2019|||

Export Product	Qty.	Sl.	Import items	Qty.
		No.
CLINDAMYCIN	1 Number	1	CLINDAMYCIN PHOSPHATE	831.13 mg
INJECTION 600MG / 4 ML			USP

Case No.:805/15/82-	Party Name:DEEPAK	Meet No/Date:4/82-	Status:
ALC4/2018	NOVOCHEM	ALC4/2020	Rejected
	TECHNOLOGIES LTD	18.09.2020
HQ File	RLA File	Lic.No/Date:3110067278
:01/82/050/02262/AM19/	:31/83/040/00157/AM19/	09.01.2019

Decision: The Committee considered the case as per Agenda and it was noted that the firm still has not furnished the information on following deficiencies raised by NC-3 in its Meeting No. 9/82-ALC4/2019 229 dated 18.10.2019, followed by Reminder on 09.12.2019 and Final Reminder on 19.03.2020 :

(i) Catalogue of OCP. (ii) Certificate of Analysis (CoA) of OCP. (iii) Percentage yield on molar basis.

2019,** followed by Reminder on 09.12.2019 and Final Reminder on 19.03.2020 :

(i) Catalogue of OCP. (ii) Certificate of Analysis (CoA) of OCP. (iii) Percentage yield on molar basis.

	Case No.:123/15/82-	Party Name:REYAANSH	Meet No/Date:4/82-		Status:
	ALC4/2018	HEALTHCARE	ALC4/2020		Deferred
			18.09.2020
230	HQ File	RLA File	Lic.No/Date:0310826282
	:01/82/050/01580/AM19/	:03/95/040/01019/AM19/	10.01.2019
	Decision:The Committee considered the case as per agenda in the presence of technical			experts and it
	was noted that the firm vide e-mail dated 25.03.2020 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 25.03.2020 has furnished its reply. Deferred for comments of TE.

	Case No.:811/15/82-	Party Name:ATUL LIMITED,	Meet No/Date:4/82-		Status:
	ALC4/2018		ALC4/2020		Deferred
			18.09.2020
231	HQ File	RLA File	Lic.No/Date:0810144290
	:01/82/050/02268/AM19/	:08/24/040/00328/AM19/	10.01.2019
	Decision:The Committee considered the case as per agenda in the presence of technical			experts and it
	was noted that the firm vide e-mail dated 11.11.2019 has furnished its reply. Deferred for comments of TE.

d the case as per agenda in the presence of technical|||||experts and it|| |||was noted that the firm vide e-mail dated 11.11.2019 has furnished its reply. Deferred for comments of TE.|||||||

232	Case No.:812/15/82-<br>ALC4/2018	Party Name:BALAJI AMINES<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02269/AM19/	RLA File<br>:31/83/040/00158/AM19/	Lic.No/Date:3110067279<br>10.01.2019
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide e-mail dated 13.12.2019 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide e-mail dated 13.12.2019 has furnished its reply. Deferred for comments of TE.

Case No.:847/15/82-	Party Name:LIRICON	Meet No/Date:4/82-	Status:
ALC4/2018	TRADING	ALC4/2020	Deferred
		18.09.2020
HQ File	RLA File	Lic.No/Date:0310826653
:01/82/050/02304/AM19/	:03/95/040/01055/AM19/	25.01.2019

233 Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was decided to call for following information from the firm:

(i) Information given in the description of Export Product appears to be incorrect and also the import quantity is not matching with the export product. Please clarify it.

n from the firm:

(i) Information given in the description of Export Product appears to be incorrect and also the import quantity is not matching with the export product. Please clarify it.

234	Case No.:51/4/82-ALC4/2020	Party Name:SIRMAXO<br>CHEMICALS PVT LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01552/AM21/	RLA File<br>:03/95/040/00252/AM20/	Lic.No/Date:0310829902<br>25.06.2019
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy<br>of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No.<br>23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

235	Case No.:89/4/82-ALC4/2020	Party Name:SPANSULES<br>FORMULATIONS	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01590/AM21/	RLA File<br>:09/24/040/00202/AM20/	Lic.No/Date:0910067792<br>17.07.2019
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy<br>of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No.<br>23/2015-20,dated 15.05.2019.

not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

236	Case No.:96/4/82-ALC4/2020	Party Name:SRINI<br>PHARMACEUTICALS<br>PRIVATE LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01597/AM21/	RLA File<br>:09/24/040/00642/AM19/	Lic.No/Date:0910067796<br>19.07.2019
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy<br>of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No.<br>23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

237	<br>Case No.:49/4/82-ALC4/2020	Party Name:SI GROUP -<br>INDIA PRIVATE LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01550/AM21/	RLA File<br>:03/95/040/00390/AM20/	Lic.No/Date:0310830654<br>29.07.2019
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

Case No.:90/4/82-ALC4/2020	Party Name:HETERO DRUGS	Meet No/Date:4/82-	Status:
	LIMITED	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:0910068010
:01/82/050/01591/AM21/	:09/24/040/00303/AM20/	20.09.2019

Qty.	Sl.<br>No.	Import items<br>	Qty.
1 kg	1	2-AMINO-6-CHLORO PURINE<br>	1.11 kg
	2	SODIUM BORO HYDRIDE<br>	0.83 kg
	3	N,N-Dimethyl formamide<br>	4.00 kg

Qty.	Sl.<br>No.	Import items<br>	Qty.
1 kg	1	2-AMINO-6-CHLORO PURINE<br>	1.11 kg
	2	SODIUM BORO HYDRIDE<br>	0.83 kg
	3	N,N-Dimethyl formamide<br>	4.00 kg

239	Case No.:91/4/82-ALC4/2020	Party Name:AURORE LIFE<br>SCIENCES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01592/AM21/	RLA File<br>:09/24/040/00328/AM20/	Lic.No/Date:0910068021<br>23.09.2019
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy<br>of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No.<br>23/2015-20,dated 15.05.2019.

240	<br>Case No.:47/4/82-ALC4/2020	Party Name:CIPLA LIMITED.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01548/AM21/	RLA File<br>:03/94/040/00528/AM20/	Lic.No/Date:0310832045<br>07.10.2019
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

1548/AM21/|RLA File :03/94/040/00528/AM20/|Lic.No/Date:0310832045 07.10.2019|| ||**Decision:**This case appeared for the first time before Norms Committee. Deferred for comments of TE.||||

241	<br>Case No.:48/4/82-ALC4/2020	Party Name:CIPLA LIMITED.	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01549/AM21/	RLA File<br>:03/94/040/00591/AM20/	Lic.No/Date:0310832572<br>04.11.2019
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

Case No.:97/4/82-ALC4/2020	Party Name:PHALANX LABS	Meet No/Date:4/82-	Status:
	PRIVATE LIMITED	ALC4/2020	Approved
		18.09.2020
HQ File	RLA File	Lic.No/Date:2610012885
:01/82/050/01598/AM21/	:26/24/040/00011/AM20/	15.11.2019

Decision: The Committee considered the case as per agenda in the presence of Technical Experts in light of the earlier decision taken by NC in its Meeting No. 10/82-ALC4/2019 242 , dated 29.11.2019 for advance authorization No. 0910068087 dated 15.10.2019, it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export product Qty. Sl. Import items Qty. No. LEVETIRACETAM 1 kg 1 (S)+2 AMINO BUTYRAMIDE HCL 0.95 kg RA concerned may take further necessary action as per above decision of NC.

whichever is lower: Export product Qty. Sl. Import items Qty. No. LEVETIRACETAM 1 kg 1 (S)+2 AMINO BUTYRAMIDE HCL 0.95 kg RA concerned may take further necessary action as per above decision of NC.

243	<br>Case No.:92/4/82-ALC4/2020	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01593/AM21/	RLA File<br>:09/24/040/00449/AM20/	Lic.No/Date:0910068271<br>10.12.2019
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

	Case No.:93/4/82-ALC4/2020	Party Name:SREEPATHI	Meet No/Date:4/82-	Status:
		PHARMACEUTICALS LTD	ALC4/2020	Deferred
			18.09.2020
244	HQ File	RLA File	Lic.No/Date:0910068349
	:01/82/050/01594/AM21/	:09/24/040/00502/AM20/	09.01.2020
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

	Case No.:94/4/82-ALC4/2020	Party Name:DIVIS	Meet No/Date:4/82-	Status:
		LABORATORIES LTD	ALC4/2020	Deferred
			18.09.2020
245	HQ File	RLA File	Lic.No/Date:0910068355
	:01/82/050/01595/AM21/	:09/24/040/00509/AM20/	09.01.2020
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

e:0910068355||| |||:01/82/050/01595/AM21/||:09/24/040/00509/AM20/||09.01.2020||| |||**Decision:**This case appeared for the first time before Norms Committee. Deferred for comments of TE.|||||||

	Case No.:99/4/82-ALC4/2020	Party Name:MICRO LABS	Meet No/Date:4/82-	Status:
		LTD	ALC4/2020	Deferred
246	HQ File	RLA File	18.09.2020<br>Lic.No/Date:0710116065
	:01/82/050/01600/AM21/	:07/24/040/00254/AM20/	24.01.2020
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

	Case No.:50/4/82-ALC4/2020	Party Name:MAGNOLIA	Meet No/Date:4/82-	Status:
		LIMITED.	ALC4/2020	Deferred
			18.09.2020
247	HQ File	RLA File	Lic.No/Date:0310834718
	:01/82/050/01551/AM21/	:03/95/040/01071/AM20/	07.02.2020
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

Case No.:53/4/82-ALC4/2020	Party Name:KOPRAN	Meet No/Date:4/82-	Status:
	RESEARCH	ALC4/2020	Approved
	LABORATORIES LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0310835023
:01/82/050/01554/AM21/	:03/94/040/00915/AM20/	24.02.2020

in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or 248 as applied by firm whichever is lower:

Export Product	Qty.	Sl.	Import items	Qty.
		No.
CLARITHROMYCIN GRANULES 43%	1 kg	1	CLARITHROMYCIN	0.434 kg
		2	ACETONE	1.00 kg

Case No.:95/4/82-ALC4/2020	Party Name:LANTECH	Meet No/Date:4/82-	Status:
	PHARMACEUTICALS	ALC4/2020	Approved
	LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0910068511
:01/82/050/01596/AM21/	:09/24/040/00580/AM20/	25.02.2020

	Case No.:95/4/82-ALC4/2020	Party Name:LANTECH<br>PHARMACEUTICALS<br>LIMITED	Party Name:LANTECH<br>PHARMACEUTICALS<br>LIMITED	Party Name:LANTECH<br>PHARMACEUTICALS<br>LIMITED	Party Name:LANTECH<br>PHARMACEUTICALS<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Approved
	HQ File<br>:01/82/050/01596/AM21/	RLA File<br>:09/24/040/00580/AM20/				Lic.No/Date:0910068511<br>25.02.2020
249	Decision:The Committee considered case a<br>was decided to ratify the ad-hoc input output n<br>as applied by firm whichever is lower:
	Export Product		Qty.	Sl.<br>No.	Import items		Qty.
	(2R,5S)-5-(4-Amino-5-fluoro-2-oxo-<br>2H-pyrimidin-1-yl)-[1,3]oxathiolane-<br>2-carboxylic<br>acid<br>(1R,2S,5R)-<br>menthyl ester		1 kg	1	Menthol(L-Menthol)		0.61 kg
				2	Glyoxalic acid(50%)		0.68 kg
				3	Cyclohexane		0.61 kg

2H-pyrimidin-1-yl)-[1,3]oxathiolane- 2-carboxylic acid (1R,2S,5R)- menthyl ester||1 kg|1|Menthol(L-Menthol)||0.61 kg| |||||2|Glyoxalic acid(50%)||0.68 kg| |||||3|Cyclohexane||0.61 kg| |||||4|2,5-Dihydroxy-1,4-dithiane||0.28 kg| |||||5|Toluene||0.41 kg| |||||6|Hexanes||1.01 kg| |||||7|Triethylamine||0.13 kg| |||||8|Triphosgene||0.42 kg| |||||9|5-Fluoro cytosine||0.49 kg| |||||10|Hexamethyldisilazane||0.53 kg| |||||11|Methylene dichloride||1.87 kg| |||||12|Methyl tert-butyl ether||3.39 kg| |||||13|Methanol||0.93 kg| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

Case No.:52/4/82-ALC4/2020	Party Name:KOPRAN	Meet No/Date:4/82-	Status:
	RESEARCH	ALC4/2020	Approved
	LABORATORIES LIMITED	18.09.2020
HQ File	RLA File	Lic.No/Date:0310835123
:01/82/050/01553/AM21/	:03/94/040/00909/AM20/	28.02.2020

-|---|---| |||RESEARCH||ALC4/2020||Approved| |||LABORATORIES LIMITED||18.09.2020||| |HQ File||RLA File||Lic.No/Date:0310835123||| |:01/82/050/01553/AM21/||:03/94/040/00909/AM20/||28.02.2020|||

	Case No.:52/4/82-ALC4/2020	Case No.:52/4/82-ALC4/2020	Case No.:52/4/82-ALC4/2020	Case No.:52/4/82-ALC4/2020	Party Name:KOPRAN<br>RESEARCH<br>LABORATORIES LIMITED	Party Name:KOPRAN<br>RESEARCH<br>LABORATORIES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0310835123<br>28.02.2020	Status:<br>Approved<br>
	HQ File<br>:01/82/050/01553/AM21/				RLA File<br>:03/94/040/00909/AM20/
250	Decision:The Committee considered the case as per agenda in the presence of Technical Experts in light<br>of<br>the<br>earlier<br>decision<br>taken<br>by<br>NC<br>in<br>its<br>Meeting<br>No.<br>15/82-ALC4/2018<br>, dated 22.03.2019 for advance authorization No. 0310811464 dated 27.02.2017, it was decided to ratify the<br>ad-hoc input output norms under para 4.07 of HBP Vol.

eeting No. 15/82-ALC4/2018 , dated 22.03.2019 for advance authorization No. 0310811464 dated 27.02.2017, it was decided to ratify the ad-hoc input output norms under para 4.07 of HBP Vol. I as per details below or as applied by firm whichever is lower: Export product Qty. Sl. No. Import items Qty. STERILE CEFTRIAXONE SODIUM 1 kg 1 CEFTRIAXONE SODIUM (NON-STERILE) 1.04 kg 2 ACETONE 1.72 kg 3 Pack.Mat.- Alu.Can.(10kg)/Alu.Botl.Ano.2M(20L000T.8020XY) (One set cont.One Can./Alu.Botl.Ano.+In Lid+Out Lid) Relevant as per packing policy RA concerned maytake further necessaryaction asper above decision of NC.|||||||| |||Export product|Qty.|Sl. No.||Import items||Qty.| |||STERILE CEFTRIAXONE SODIUM|1 kg|1||CEFTRIAXONE SODIUM (NON-STERILE)||1.04 kg| |||||2||ACETONE||1.72 kg| |||||3||Pack.Mat.- Alu.Can.(10kg)/Alu.Botl.Ano.2M(20L000T.8020XY) (One set cont.One Can./Alu.Botl.Ano.+In Lid+Out Lid)|| Relevant as per packing policy| ||||||||||

|1.72 kg| |||||3||Pack.Mat.- Alu.Can.(10kg)/Alu.Botl.Ano.2M(20L000T.8020XY) (One set cont.One Can./Alu.Botl.Ano.+In Lid+Out Lid)|| Relevant as per packing policy| ||||||||||

251	Case No.:98/4/82-ALC4/2020	Party Name:SUN<br>PHARMACEUTICAL<br>INDUSTRIES LTD.<br>RLA File<br>:05/24/040/00742/AM20/	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020<br>Lic.No/Date:0510413763<br>02.03.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01599/AM21/
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

Decision: The Committee noted that the 4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

252	<br>Case No.:54/4/82-ALC4/2020	Party Name:ZENITH<br>DYEINTERMEDIATES<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01555/AM21/	RLA File<br>:03/95/040/01130/AM20/	Lic.No/Date:0310835403<br>16.03.2020
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

1555/AM21/|RLA File :03/95/040/01130/AM20/|Lic.No/Date:0310835403 16.03.2020|| ||**Decision:**This case appeared for the first time before Norms Committee. Deferred for comments of TE.||||

253	<br>Case No.:1/4/82-ALC4/2020	Party Name:PHAROSE<br>REMEDIES LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01502/AM21/	RLA File<br>:18/24/040/00004/AM21/	Lic.No/Date:1810004355<br>24.07.2020
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

254	Case No.:6/4/82-ALC4/2020	Party Name:SYNNAT<br>PHARMA PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01507/AM21/	RLA File<br>:02/24/040/00050/AM21/	Lic.No/Date:0210210010<br>27.07.2020
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy<br>of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No.<br>23/2015-20,dated 15.05.2019.

vailable. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20,dated 15.05.2019.||||

255	Case No.:2/4/82-ALC4/2020	Party Name:USV PRIVATE<br>LIMITED (FORMERLY USV<br>LIMITED)	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01503/AM21/	RLA File<br>:03/95/040/00235/AM21/	Lic.No/Date:0310837435<br>28.07.2020
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy<br>of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No.<br>23/2015-20,dated 15.05.2019.

ble. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20,dated 15.05.2019.||||

	Case No.:3/4/82-ALC4/2020		Party Name:SAFECON		Meet No/Date:4/82-		Status:
			LIFESCIENCES		ALC4/2020		Deferred
					18.09.2020
	HQ File		RLA File		Lic.No/Date:0610039560
256	:01/82/050/01504/AM21/		:06/24/040/00092/AM20/		28.07.2020
	Decision:This case appeared	for the first time before Norms Committee. The Committee				noted that the
	4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy
	of 4.07 application of the subject advance authorization directly			from the firm as per Policy Circular No.
	23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

	Case No.:4/4/82-ALC4/2020		Party Name:STERILE INDIA		Meet No/Date:4/82-		Status:
			PRIVATE LIMITED		ALC4/2020		Deferred
					18.09.2020
	HQ File		RLA File		Lic.No/Date:0510414761
257	:01/82/050/01505/AM21/		:05/24/040/00196/AM21/		28.07.2020
	Decision:This case appeared	for the first time before Norms Committee. The Committee				noted that the
	4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy
	of 4.07 application of the subject advance authorization directly			from the firm as per Policy Circular No.
	23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

	Case No.:5/4/82-ALC4/2020		Party Name:S.M. HERBALS		Meet No/Date:4/82-		Status:
			PRIVATE LIMITED		ALC4/2020		Deferred
					18.09.2020
	HQ File		RLA File		Lic.No/Date:0510414764
258	:01/82/050/01506/AM21/		:05/24/040/00146/AM21/		28.07.2020
	Decision:This case appeared	for the first time before Norms Committee. The Committee				noted that the
	4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy
	of 4.07 application of the subject advance authorization directly			from the firm as per Policy Circular No.
	23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

	Case No.:7/4/82-ALC4/2020		Party Name:ALPHAMED		Meet No/Date:4/82-		Status:
			FORMULATIONS P LTD.		ALC4/2020		Deferred
					18.09.2020
	HQ File		RLA File		Lic.No/Date:0910068998
259	:01/82/050/01508/AM21/		:09/24/040/00160/AM21/		28.07.2020
	Decision:This case appeared	for the first time before Norms Committee. The Committee				noted that the
	4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy
	of 4.07 application of the subject advance authorization directly			from the firm as per Policy Circular No.
	23/2015-20,dated 15.05.2019.

not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

260	Case No.:8/4/82-ALC4/2020	Party Name:STYRAX LIFE<br>SCIENCES PRIVATE<br>LIMITED	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01509/AM21/	RLA File<br>:09/24/040/00167/AM21/	Lic.No/Date:0910069002<br>28.07.2020
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy<br>of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No.<br>23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

261	<br>Case No.:9/4/82-ALC4/2020	Party Name:GLENMARK<br>PHARMACEUTICALS LTD	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01510/AM21/	RLA File<br>:03/94/040/00301/AM21/	Lic.No/Date:0310837490<br>29.07.2020
	Decision:This case appeared for the first time before Norms Committee. Deferred for comments of TE.

262	Case No.:10/4/82-ALC4/2020	Party Name:KUSUMA<br>PHARMA	Meet No/Date:4/82-<br>ALC4/2020<br>18.09.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01511/AM21/	RLA File<br>:03/94/040/00198/AM21/	Lic.No/Date:0310837494<br>29.07.2020
	Decision:This case appeared for the first time before Norms Committee. The Committee noted that the<br>4.07 application of subject A

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 7946 --apply.